Quiver News
The latest insights and financial news from Quiver Quantitative
$50,000 of GOOGLE CLIENT SERVICES LLC lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"competition issues patent legislation online privacy, safety issues"
You can find more data on corporate lobbying on Quiver Quantitative.
GOOGL Congressional Stock Trading
Members of Congress have traded $GOOGL stock 21 times in the past 6 months. Of those trades, 9 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $GOOGL stock by members of Congress over the last 6 months:
- REPRESENTATIVE DAVID TAYLOR has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 09/03.
- SENATOR SHELLEY MOORE CAPITO has traded it 3 times. They made 3 purchases worth up to $45,000 on 07/29, 05/08, 04/29 and 0 sales.
- SENATOR ANGUS S. KING JR. purchased up to $15,000 on 07/21.
- REPRESENTATIVE VAL T. HOYLE has traded it 4 times. They made 2 purchases worth up to $30,000 on 07/14, 07/02 and 2 sales worth up to $30,000 on 04/15, 04/02.
- REPRESENTATIVE RITCHIE TORRES sold up to $15,000 on 07/11.
- REPRESENTATIVE LISA C. MCCLAIN purchased up to $15,000 on 06/24.
- REPRESENTATIVE JOHN W. ROSE sold up to $5,000,000 on 06/03.
- SENATOR JOHN BOOZMAN purchased up to $15,000 on 05/20.
- REPRESENTATIVE JEFFERSON SHREVE sold up to $250,000 on 05/12.
- REPRESENTATIVE BRUCE WESTERMAN sold up to $15,000 on 04/21.
- REPRESENTATIVE JONATHAN L. JACKSON sold up to $50,000 on 04/21.
- SENATOR TOMMY TUBERVILLE sold up to $50,000 on 04/15.
- REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 04/11.
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 04/08.
- REPRESENTATIVE DWIGHT EVANS purchased up to $15,000 on 04/03.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
GOOGL Insider Trading Activity
GOOGL insiders have traded $GOOGL stock on the open market 110 times in the past 6 months. Of those trades, 0 have been purchases and 110 have been sales.
Here’s a breakdown of recent trading of $GOOGL stock by insiders over the last 6 months:
- SUNDAR PICHAI (Chief Executive Officer) has made 0 purchases and 63 sales selling 390,000 shares for an estimated $72,317,606.
- KAVITARK RAM SHRIRAM has made 0 purchases and 4 sales selling 59,566 shares for an estimated $11,565,220.
- JOHN KENT WALKER (President, Global Affairs, CLO) sold 23,820 shares for an estimated $4,637,754
- JOHN L. HENNESSY has made 0 purchases and 35 sales selling 4,000 shares for an estimated $784,712.
- AMIE THUENER O'TOOLE (VP, Chief Accounting Officer) sold 2,778 shares for an estimated $680,610
- FRANCES ARNOLD has made 0 purchases and 6 sales selling 649 shares for an estimated $124,813.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
GOOGL Hedge Fund Activity
We have seen 2,440 institutional investors add shares of GOOGL stock to their portfolio, and 2,097 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GAMMA INVESTING LLC removed 15,944,572 shares (-99.3%) from their portfolio in Q2 2025, for an estimated $2,809,911,923
- PRICE T ROWE ASSOCIATES INC /MD/ removed 14,910,314 shares (-16.7%) from their portfolio in Q2 2025, for an estimated $2,627,644,636
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 11,522,921 shares (+26.3%) to their portfolio in Q2 2025, for an estimated $2,030,684,367
- FRANKLIN RESOURCES INC added 10,843,853 shares (+51.7%) to their portfolio in Q2 2025, for an estimated $1,911,012,214
- CAPITAL RESEARCH GLOBAL INVESTORS removed 10,062,090 shares (-18.7%) from their portfolio in Q2 2025, for an estimated $1,773,242,120
- WELLINGTON MANAGEMENT GROUP LLP added 10,042,091 shares (+17.9%) to their portfolio in Q2 2025, for an estimated $1,769,717,696
- BLACKROCK, INC. removed 9,367,765 shares (-2.1%) from their portfolio in Q2 2025, for an estimated $1,650,881,225
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
GOOGL Analyst Ratings
Wall Street analysts have issued reports on $GOOGL in the last several months. We have seen 23 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Outperform" rating on 09/30/2025
- MoffettNathanson issued a "Buy" rating on 09/25/2025
- Truist Securities issued a "Buy" rating on 09/22/2025
- Piper Sandler issued a "Overweight" rating on 09/18/2025
- Citigroup issued a "Buy" rating on 09/15/2025
- Evercore ISI Group issued a "Outperform" rating on 09/08/2025
- Tigress Financial issued a "Strong Buy" rating on 09/05/2025
To track analyst ratings and price targets for GOOGL, check out Quiver Quantitative's $GOOGL forecast page.
GOOGL Price Targets
Multiple analysts have issued price targets for $GOOGL recently. We have seen 34 analysts offer price targets for $GOOGL in the last 6 months, with a median target of $228.5.
Here are some recent targets:
- Lloyd Walmsley from Mizuho set a target price of $295.0 on 09/30/2025
- Michael Nathanson from MoffettNathanson set a target price of $295.0 on 09/25/2025
- Deepak Mathivanan from Cantor Fitzgerald set a target price of $201.0 on 09/24/2025
- Youssef Squali from Truist Securities set a target price of $285.0 on 09/22/2025
- Colin Sebastian from Baird set a target price of $275.0 on 09/22/2025
- Andrew Boone from JMP Securities set a target price of $290.0 on 09/19/2025
- Thomas Champion from Piper Sandler set a target price of $285.0 on 09/18/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$50,000 of REGENERON PHARMACEUTICALS INC. lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Biodefense funding"
You can find more data on corporate lobbying on Quiver Quantitative.
REGN Congressional Stock Trading
Members of Congress have traded $REGN stock 5 times in the past 6 months. Of those trades, 1 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $REGN stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 1 purchase worth up to $15,000 on 05/15 and 1 sale worth up to $15,000 on 04/08.
- REPRESENTATIVE BYRON DONALDS has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 04/10.
- REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 04/07.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
REGN Hedge Fund Activity
We have seen 553 institutional investors add shares of REGN stock to their portfolio, and 663 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 4,271,533 shares (-56.2%) from their portfolio in Q2 2025, for an estimated $2,242,554,825
- JPMORGAN CHASE & CO removed 1,718,579 shares (-30.4%) from their portfolio in Q2 2025, for an estimated $902,253,975
- DODGE & COX added 1,502,198 shares (+64.6%) to their portfolio in Q2 2025, for an estimated $788,653,950
- PRICE T ROWE ASSOCIATES INC /MD/ removed 1,408,582 shares (-64.8%) from their portfolio in Q2 2025, for an estimated $739,505,550
- CAPITAL INTERNATIONAL INVESTORS removed 823,869 shares (-20.7%) from their portfolio in Q2 2025, for an estimated $432,531,225
- GAMMA INVESTING LLC removed 814,345 shares (-99.8%) from their portfolio in Q2 2025, for an estimated $427,531,125
- AMUNDI removed 706,770 shares (-44.1%) from their portfolio in Q2 2025, for an estimated $371,054,250
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
REGN Analyst Ratings
Wall Street analysts have issued reports on $REGN in the last several months. We have seen 11 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- BMO Capital issued a "Outperform" rating on 08/04/2025
- Canaccord Genuity issued a "Buy" rating on 07/23/2025
- JP Morgan issued a "Overweight" rating on 06/09/2025
- Morgan Stanley issued a "Overweight" rating on 06/02/2025
- Citigroup issued a "Buy" rating on 06/02/2025
- RBC Capital issued a "Outperform" rating on 05/27/2025
- Guggenheim issued a "Buy" rating on 05/01/2025
To track analyst ratings and price targets for REGN, check out Quiver Quantitative's $REGN forecast page.
REGN Price Targets
Multiple analysts have issued price targets for $REGN recently. We have seen 17 analysts offer price targets for $REGN in the last 6 months, with a median target of $761.0.
Here are some recent targets:
- William Pickering from Bernstein set a target price of $781.0 on 08/27/2025
- Akash Tewari from Jefferies set a target price of $831.0 on 08/27/2025
- Srikripa Devarakonda from Truist Securities set a target price of $812.0 on 08/11/2025
- Brian Abrahams from RBC Capital set a target price of $695.0 on 08/04/2025
- Matthew Harrison from Morgan Stanley set a target price of $761.0 on 08/04/2025
- Evan David Seigerman from BMO Capital set a target price of $640.0 on 08/04/2025
- Yatin Suneja from Guggenheim set a target price of $815.0 on 08/04/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$80,000 of SIGA TECHNOLOGIES lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Biodefense funding"
You can find more data on corporate lobbying on Quiver Quantitative.
SIGA Hedge Fund Activity
We have seen 96 institutional investors add shares of SIGA stock to their portfolio, and 72 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC removed 1,090,560 shares (-34.5%) from their portfolio in Q2 2025, for an estimated $7,110,451
- FIRST WILSHIRE SECURITIES MANAGEMENT INC removed 889,640 shares (-56.1%) from their portfolio in Q2 2025, for an estimated $5,800,452
- JACOBS LEVY EQUITY MANAGEMENT, INC added 438,854 shares (+inf%) to their portfolio in Q2 2025, for an estimated $2,861,328
- CSM ADVISORS, LLC added 358,257 shares (+inf%) to their portfolio in Q2 2025, for an estimated $2,335,835
- BANK OF AMERICA CORP /DE/ added 238,869 shares (+143.2%) to their portfolio in Q2 2025, for an estimated $1,557,425
- GOLDMAN SACHS GROUP INC added 238,411 shares (+84.2%) to their portfolio in Q2 2025, for an estimated $1,554,439
- CITADEL ADVISORS LLC added 233,682 shares (+20.1%) to their portfolio in Q2 2025, for an estimated $1,523,606
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$20,000 of HNI CORPORATION lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Shared information regarding the scope of products HNI manufactures and our manufacturing footprint. Broadly shared information on how tariffs may impact our operations. Discussed the potential impact of New Source Performance Standards for wood heaters, a new federal reference method for testing those products, and overall impact of these regulations on our residential building products division. Emphasized the need for manufacturer input and that any changes will require our company to redesign products, additional testing and compliance efforts. Urged adoption of realistic emissions standards that manufacturers can meet with an appropriate transition period. Notified lawmakers about the repeal of the Biomass Tax Credit retaining the Biomass Tax Credit, a piece of the Energy Efficient Home Improvement Tax Credit/25C. Explained how loss of the tax credit hurts the market for wood heaters, and our dealers who sell them."
You can find more data on corporate lobbying on Quiver Quantitative.
HNI Congressional Stock Trading
Members of Congress have traded $HNI stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $HNI stock by members of Congress over the last 6 months:
- REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 05/08.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
HNI Insider Trading Activity
HNI insiders have traded $HNI stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $HNI stock by insiders over the last 6 months:
- MIGUEL M CALADO has made 0 purchases and 2 sales selling 3,743 shares for an estimated $192,379.
- JASON DEAN HAGEDORN (President, Allsteel LLC) sold 1,440 shares for an estimated $67,780
- JEFFREY D LORENGER (President & CEO) has made 0 purchases and 2 sales selling 200 shares for an estimated $10,658.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
HNI Hedge Fund Activity
We have seen 112 institutional investors add shares of HNI stock to their portfolio, and 136 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ADAGE CAPITAL PARTNERS GP, L.L.C. added 872,000 shares (+348.8%) to their portfolio in Q2 2025, for an estimated $42,884,960
- BLACKROCK, INC. removed 508,444 shares (-6.9%) from their portfolio in Q2 2025, for an estimated $25,005,275
- ROYAL BANK OF CANADA added 349,776 shares (+4047.4%) to their portfolio in Q2 2025, for an estimated $17,201,983
- SG CAPITAL MANAGEMENT LLC removed 264,829 shares (-65.9%) from their portfolio in Q2 2025, for an estimated $13,024,290
- JONES FINANCIAL COMPANIES LLLP removed 234,098 shares (-99.9%) from their portfolio in Q2 2025, for an estimated $11,512,939
- PENN CAPITAL MANAGEMENT COMPANY, LLC added 180,145 shares (+inf%) to their portfolio in Q2 2025, for an estimated $8,859,531
- CERITY PARTNERS LLC removed 168,107 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $8,267,502
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
HNI Analyst Ratings
Wall Street analysts have issued reports on $HNI in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Longbow Research issued a "Buy" rating on 05/16/2025
To track analyst ratings and price targets for HNI, check out Quiver Quantitative's $HNI forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$50,000 of DAVITA lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Dialysis services, HR3944 - military construction, Veterans Affairs, and related agencies appropriations Act"
You can find more data on corporate lobbying on Quiver Quantitative.
DVA Insider Trading Activity
DVA insiders have traded $DVA stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $DVA stock by insiders over the last 6 months:
- HATHAWAY INC BERKSHIRE has made 0 purchases and 10 sales selling 2,981,900 shares for an estimated $426,370,810.
- JAMES O HEARTY (Chief Compliance Officer) sold 2,351 shares for an estimated $352,650
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
DVA Hedge Fund Activity
We have seen 244 institutional investors add shares of DVA stock to their portfolio, and 298 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BERKSHIRE HATHAWAY INC removed 1,345,938 shares (-3.8%) from their portfolio in Q2 2025, for an estimated $191,728,868
- PACER ADVISORS, INC. added 456,285 shares (+4437.7%) to their portfolio in Q2 2025, for an estimated $64,997,798
- HOLOCENE ADVISORS, LP removed 409,638 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $58,352,933
- EPOCH INVESTMENT PARTNERS, INC. removed 399,500 shares (-97.9%) from their portfolio in Q2 2025, for an estimated $56,908,774
- GATES CAPITAL MANAGEMENT, INC. added 376,775 shares (+52.2%) to their portfolio in Q2 2025, for an estimated $53,671,598
- IRON TRIANGLE PARTNERS LP removed 319,566 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $45,522,176
- VANGUARD GROUP INC removed 306,538 shares (-6.1%) from their portfolio in Q2 2025, for an estimated $43,666,338
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
DVA Analyst Ratings
Wall Street analysts have issued reports on $DVA in the last several months. We have seen 0 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- B of A Securities issued a "Underperform" rating on 09/10/2025
To track analyst ratings and price targets for DVA, check out Quiver Quantitative's $DVA forecast page.
DVA Price Targets
Multiple analysts have issued price targets for $DVA recently. We have seen 3 analysts offer price targets for $DVA in the last 6 months, with a median target of $160.0.
Here are some recent targets:
- Kevin Fischbeck from B of A Securities set a target price of $140.0 on 09/10/2025
- Andrew Mok from Barclays set a target price of $160.0 on 08/07/2025
- David Macdonald from Truist Securities set a target price of $164.0 on 05/19/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$50,000 of KIRBY CORPORATION lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Energy & Water Appropriations for FY2025 and FY2026. Opposing changes to the Merchant Marine Act of 1920; and Marine safety issues in the upcoming Coast Guard Authorization Act."
You can find more data on corporate lobbying on Quiver Quantitative.
KEX Congressional Stock Trading
Members of Congress have traded $KEX stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $KEX stock by members of Congress over the last 6 months:
- SENATOR ANGUS S. KING JR. purchased up to $15,000 on 07/21.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
KEX Hedge Fund Activity
We have seen 206 institutional investors add shares of KEX stock to their portfolio, and 193 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ALLIANCEBERNSTEIN L.P. added 959,209 shares (+72.5%) to their portfolio in Q2 2025, for an estimated $108,783,892
- HOOD RIVER CAPITAL MANAGEMENT LLC added 650,595 shares (+inf%) to their portfolio in Q2 2025, for an estimated $73,783,978
- ENCOMPASS CAPITAL ADVISORS LLC added 299,981 shares (+32.4%) to their portfolio in Q2 2025, for an estimated $34,020,845
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC added 289,370 shares (+inf%) to their portfolio in Q2 2025, for an estimated $32,817,451
- VANGUARD GROUP INC removed 255,962 shares (-4.4%) from their portfolio in Q2 2025, for an estimated $29,028,650
- JENNISON ASSOCIATES LLC removed 254,429 shares (-19.6%) from their portfolio in Q2 2025, for an estimated $28,854,792
- CITADEL ADVISORS LLC added 234,300 shares (+249.2%) to their portfolio in Q2 2025, for an estimated $26,571,963
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
KEX Analyst Ratings
Wall Street analysts have issued reports on $KEX in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 09/18/2025
- B of A Securities issued a "Buy" rating on 09/03/2025
To track analyst ratings and price targets for KEX, check out Quiver Quantitative's $KEX forecast page.
KEX Price Targets
Multiple analysts have issued price targets for $KEX recently. We have seen 3 analysts offer price targets for $KEX in the last 6 months, with a median target of $107.0.
Here are some recent targets:
- Ben Mohr from Citigroup set a target price of $91.0 on 09/22/2025
- Gregory Lewis from BTIG set a target price of $125.0 on 09/18/2025
- Ken Hoexter from B of A Securities set a target price of $107.0 on 09/03/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$45,000 of WERNER ENTERPRISES lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Transportation"
You can find more data on corporate lobbying on Quiver Quantitative.
WERN Hedge Fund Activity
We have seen 126 institutional investors add shares of WERN stock to their portfolio, and 133 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 2,147,555 shares (+19286.5%) to their portfolio in Q2 2025, for an estimated $58,757,104
- MACQUARIE GROUP LTD removed 527,126 shares (-16.1%) from their portfolio in Q2 2025, for an estimated $14,422,167
- DEPRINCE RACE & ZOLLO INC added 483,344 shares (+22.3%) to their portfolio in Q2 2025, for an estimated $13,224,291
- BALYASNY ASSET MANAGEMENT L.P. added 474,140 shares (+inf%) to their portfolio in Q2 2025, for an estimated $12,972,470
- FIRST TRUST ADVISORS LP added 424,935 shares (+17.2%) to their portfolio in Q2 2025, for an estimated $11,626,221
- BLACKROCK, INC. removed 369,299 shares (-3.9%) from their portfolio in Q2 2025, for an estimated $10,104,020
- WELLINGTON MANAGEMENT GROUP LLP added 350,251 shares (+inf%) to their portfolio in Q2 2025, for an estimated $9,582,867
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
WERN Analyst Ratings
Wall Street analysts have issued reports on $WERN in the last several months. We have seen 1 firms issue buy ratings on the stock, and 4 firms issue sell ratings.
Here are some recent analyst ratings:
- Evercore ISI Group issued a "Underperform" rating on 09/30/2025
- B of A Securities issued a "Underperform" rating on 09/10/2025
- Wells Fargo issued a "Underweight" rating on 07/30/2025
- Baird issued a "Underperform" rating on 07/01/2025
- Goldman Sachs issued a "Buy" rating on 06/02/2025
To track analyst ratings and price targets for WERN, check out Quiver Quantitative's $WERN forecast page.
WERN Price Targets
Multiple analysts have issued price targets for $WERN recently. We have seen 10 analysts offer price targets for $WERN in the last 6 months, with a median target of $25.5.
Here are some recent targets:
- Jonathan Chappell from Evercore ISI Group set a target price of $23.0 on 09/30/2025
- Bascome Majors from Susquehanna set a target price of $23.0 on 09/24/2025
- Ken Hoexter from B of A Securities set a target price of $26.0 on 09/10/2025
- Christian Wetherbee from Wells Fargo set a target price of $25.0 on 07/30/2025
- Ariel Rosa from Citigroup set a target price of $31.0 on 07/09/2025
- Daniel Moore from Baird set a target price of $25.0 on 07/01/2025
- Jordan Alliger from Goldman Sachs set a target price of $39.0 on 06/02/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$45,000 of OLD DOMINION FREIGHT LINE INC. lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Transportation"
You can find more data on corporate lobbying on Quiver Quantitative.
ODFL Congressional Stock Trading
Members of Congress have traded $ODFL stock 4 times in the past 6 months. Of those trades, 4 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $ODFL stock by members of Congress over the last 6 months:
- REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 3 times. They made 3 purchases worth up to $45,000 on 05/05, 04/04, 04/03 and 0 sales.
- REPRESENTATIVE ROBERT BRESNAHAN purchased up to $15,000 on 04/08.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
ODFL Hedge Fund Activity
We have seen 466 institutional investors add shares of ODFL stock to their portfolio, and 394 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CIBC PRIVATE WEALTH GROUP LLC removed 5,084,912 shares (-58.6%) from their portfolio in Q2 2025, for an estimated $825,281,217
- BLACKROCK, INC. removed 2,021,753 shares (-12.0%) from their portfolio in Q2 2025, for an estimated $328,130,511
- DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN removed 1,831,623 shares (-75.8%) from their portfolio in Q2 2025, for an estimated $297,272,412
- INVESCO LTD. removed 940,907 shares (-22.0%) from their portfolio in Q2 2025, for an estimated $152,709,206
- CLEARBRIDGE INVESTMENTS, LLC added 702,330 shares (+71.9%) to their portfolio in Q2 2025, for an estimated $113,988,159
- FMR LLC removed 621,853 shares (-25.6%) from their portfolio in Q2 2025, for an estimated $100,926,741
- FIRST TRUST ADVISORS LP added 592,605 shares (+63.8%) to their portfolio in Q2 2025, for an estimated $96,179,791
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ODFL Analyst Ratings
Wall Street analysts have issued reports on $ODFL in the last several months. We have seen 6 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 09/10/2025
- Raymond James issued a "Outperform" rating on 07/31/2025
- Wells Fargo issued a "Underweight" rating on 07/31/2025
- Stifel issued a "Buy" rating on 07/31/2025
- Stephens & Co. issued a "Overweight" rating on 07/31/2025
- Truist Securities issued a "Buy" rating on 06/30/2025
- Goldman Sachs issued a "Buy" rating on 06/02/2025
To track analyst ratings and price targets for ODFL, check out Quiver Quantitative's $ODFL forecast page.
ODFL Price Targets
Multiple analysts have issued price targets for $ODFL recently. We have seen 16 analysts offer price targets for $ODFL in the last 6 months, with a median target of $165.0.
Here are some recent targets:
- Jonathan Chappell from Evercore ISI Group set a target price of $143.0 on 09/30/2025
- Ariel Rosa from Citigroup set a target price of $173.0 on 09/10/2025
- Daniel Moore from Baird set a target price of $148.0 on 08/04/2025
- Daniel Imbro from Stephens & Co. set a target price of $174.0 on 07/31/2025
- Thomas Wadewitz from UBS set a target price of $155.0 on 07/31/2025
- Patrick Tyler Brown from Raymond James set a target price of $165.0 on 07/31/2025
- Ravi Shanker from Morgan Stanley set a target price of $165.0 on 07/31/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$30,000 of FIRST BANK OF THE LAKE lobbying was just disclosed, from Q2 of 2024, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Small business lending issues. H.R. 8773 - Financial Services and General Government Appropriations Act, 2025/Senate Financial Services and General Government Appropriations, FY 2025."
You can find more data on corporate lobbying on Quiver Quantitative.
FRBA Hedge Fund Activity
We have seen 50 institutional investors add shares of FRBA stock to their portfolio, and 38 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WILMINGTON SAVINGS FUND SOCIETY, FSB removed 254,719 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $3,940,502
- BANC FUNDS CO LLC removed 211,800 shares (-17.6%) from their portfolio in Q2 2025, for an estimated $3,276,546
- OSAIC HOLDINGS, INC. added 195,155 shares (+4782.0%) to their portfolio in Q2 2025, for an estimated $3,019,047
- CSM ADVISORS, LLC added 138,190 shares (+inf%) to their portfolio in Q2 2025, for an estimated $2,137,799
- BLACKROCK, INC. added 69,926 shares (+3.7%) to their portfolio in Q2 2025, for an estimated $1,081,755
- VANGUARD GROUP INC added 53,332 shares (+4.4%) to their portfolio in Q2 2025, for an estimated $825,046
- ROYCE & ASSOCIATES LP added 49,121 shares (+20.2%) to their portfolio in Q2 2025, for an estimated $759,901
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
FRBA Analyst Ratings
Wall Street analysts have issued reports on $FRBA in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- DA Davidson issued a "Buy" rating on 07/24/2025
To track analyst ratings and price targets for FRBA, check out Quiver Quantitative's $FRBA forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$75,000 of CONOCOPHILLIPS lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"None"
You can find more data on corporate lobbying on Quiver Quantitative.
COP Congressional Stock Trading
Members of Congress have traded $COP stock 15 times in the past 6 months. Of those trades, 7 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $COP stock by members of Congress over the last 6 months:
- REPRESENTATIVE DAN NEWHOUSE purchased up to $15,000 on 08/18.
- REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 08/14, 04/01.
- REPRESENTATIVE LISA C. MCCLAIN purchased up to $15,000 on 06/24.
- REPRESENTATIVE JOSH GOTTHEIMER sold up to $15,000 on 06/24.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 05/30.
- REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 1 purchase worth up to $50,000 on 05/15 and 1 sale worth up to $15,000 on 04/08.
- SENATOR MARKWAYNE MULLIN has traded it 2 times. They made 1 purchase worth up to $50,000 on 05/13 and 1 sale worth up to $50,000 on 04/08.
- REPRESENTATIVE JEFFERSON SHREVE has traded it 3 times. They made 2 purchases worth up to $100,000 on 04/11, 04/07 and 1 sale worth up to $50,000 on 05/12.
- REPRESENTATIVE VAL T. HOYLE purchased up to $15,000 on 04/29.
- REPRESENTATIVE BRUCE WESTERMAN sold up to $15,000 on 04/21.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
COP Insider Trading Activity
COP insiders have traded $COP stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $COP stock by insiders over the last 6 months:
- KIRK L. JOHNSON (Executive Vice President) purchased 5,300 shares for an estimated $499,472
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
COP Hedge Fund Activity
We have seen 1,012 institutional investors add shares of COP stock to their portfolio, and 1,270 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO removed 12,381,010 shares (-24.5%) from their portfolio in Q2 2025, for an estimated $1,111,071,837
- FMR LLC added 10,167,065 shares (+163.1%) to their portfolio in Q2 2025, for an estimated $912,392,413
- BLACKROCK, INC. removed 9,263,082 shares (-9.2%) from their portfolio in Q2 2025, for an estimated $831,268,978
- PRICE T ROWE ASSOCIATES INC /MD/ added 3,507,962 shares (+8.8%) to their portfolio in Q2 2025, for an estimated $314,804,509
- AQR CAPITAL MANAGEMENT LLC removed 3,335,339 shares (-71.5%) from their portfolio in Q2 2025, for an estimated $299,313,321
- PRIMECAP MANAGEMENT CO/CA/ added 3,135,315 shares (+66.0%) to their portfolio in Q2 2025, for an estimated $281,363,168
- CAPITAL INTERNATIONAL INVESTORS added 3,110,206 shares (+8.8%) to their portfolio in Q2 2025, for an estimated $279,109,886
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
COP Analyst Ratings
Wall Street analysts have issued reports on $COP in the last several months. We have seen 10 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Outperform" rating on 09/15/2025
- Raymond James issued a "Outperform" rating on 09/08/2025
- UBS issued a "Buy" rating on 08/20/2025
- Piper Sandler issued a "Overweight" rating on 08/18/2025
- Morgan Stanley issued a "Overweight" rating on 08/11/2025
- Susquehanna issued a "Positive" rating on 07/23/2025
- RBC Capital issued a "Outperform" rating on 07/11/2025
To track analyst ratings and price targets for COP, check out Quiver Quantitative's $COP forecast page.
COP Price Targets
Multiple analysts have issued price targets for $COP recently. We have seen 13 analysts offer price targets for $COP in the last 6 months, with a median target of $117.0.
Here are some recent targets:
- Nitin Kumar from Mizuho set a target price of $120.0 on 09/15/2025
- John Freeman from Raymond James set a target price of $115.0 on 09/08/2025
- James West from Melius Research set a target price of $117.0 on 08/20/2025
- Josh Silverstein from UBS set a target price of $124.0 on 08/20/2025
- Ryan Todd from Piper Sandler set a target price of $124.0 on 08/18/2025
- Devin McDermott from Morgan Stanley set a target price of $123.0 on 08/11/2025
- Biju Perincheril from Susquehanna set a target price of $113.0 on 07/23/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$10,000 of ENERSYS ADVANCE SYSTEMS INC lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"None"
You can find more data on corporate lobbying on Quiver Quantitative.
ENS Insider Trading Activity
ENS insiders have traded $ENS stock on the open market 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $ENS stock by insiders over the last 6 months:
- SHAWN M. O'CONNELL (President & CEO) purchased 475 shares for an estimated $39,786
- ANDREA J. FUNK (EVP & Chief Financial Officer) purchased 315 shares for an estimated $25,263
- CHAD C UPLINGER (Pres., Motive Power Global) purchased 295 shares for an estimated $24,676
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ENS Hedge Fund Activity
We have seen 170 institutional investors add shares of ENS stock to their portfolio, and 225 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC removed 461,871 shares (-74.8%) from their portfolio in Q2 2025, for an estimated $39,614,675
- JANUS HENDERSON GROUP PLC removed 395,473 shares (-39.2%) from their portfolio in Q2 2025, for an estimated $33,919,719
- OPHIR ASSET MANAGEMENT PTY LTD added 309,905 shares (+inf%) to their portfolio in Q2 2025, for an estimated $26,580,551
- ALLIANZ ASSET MANAGEMENT GMBH added 305,635 shares (+249.0%) to their portfolio in Q2 2025, for an estimated $26,214,313
- BLACKROCK, INC. removed 286,048 shares (-5.7%) from their portfolio in Q2 2025, for an estimated $24,534,336
- NEW SOUTH CAPITAL MANAGEMENT INC added 195,324 shares (+38.8%) to their portfolio in Q2 2025, for an estimated $16,752,939
- PRINCIPAL FINANCIAL GROUP INC removed 145,722 shares (-21.9%) from their portfolio in Q2 2025, for an estimated $12,498,575
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ENS Analyst Ratings
Wall Street analysts have issued reports on $ENS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Roth MKM issued a "Buy" rating on 05/14/2025
To track analyst ratings and price targets for ENS, check out Quiver Quantitative's $ENS forecast page.
ENS Price Targets
Multiple analysts have issued price targets for $ENS recently. We have seen 2 analysts offer price targets for $ENS in the last 6 months, with a median target of $120.0.
Here are some recent targets:
- Chip Moore from Roth Capital set a target price of $120.0 on 08/05/2025
- Chip Moore from Roth MKM set a target price of $120.0 on 05/14/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$21,000 of STARBUCKS CORP. lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Working with the Administration trade agreements impacting the food and beverage industry. Potential reforms regarding food ingredients and additives and initiatives aimed at addressing healthier food options. Issues related to proposed changes to nutritional guidelines and ingredients. Working with the administration on trade agreements impacting the food and beverage industry."
You can find more data on corporate lobbying on Quiver Quantitative.
SBUX Congressional Stock Trading
Members of Congress have traded $SBUX stock 16 times in the past 6 months. Of those trades, 3 have been purchases and 13 have been sales.
Here’s a breakdown of recent trading of $SBUX stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 2 purchases worth up to $30,000 on 07/22, 06/17 and 1 sale worth up to $15,000 on 06/24.
- REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 05/05.
- REPRESENTATIVE BRUCE WESTERMAN sold up to $15,000 on 04/21.
- REPRESENTATIVE JOSH GOTTHEIMER has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 04/17, 04/09.
- SENATOR SHELDON WHITEHOUSE has traded it 3 times. They made 0 purchases and 3 sales worth up to $80,000 on 04/14, 04/11.
- REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 04/11.
- REPRESENTATIVE JARED MOSKOWITZ has traded it 3 times. They made 0 purchases and 3 sales worth up to $45,000 on 04/10.
- REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 04/07.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 04/01.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
SBUX Hedge Fund Activity
We have seen 996 institutional investors add shares of SBUX stock to their portfolio, and 1,362 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL RESEARCH GLOBAL INVESTORS added 41,264,059 shares (+116.5%) to their portfolio in Q2 2025, for an estimated $3,781,025,726
- JPMORGAN CHASE & CO removed 12,171,772 shares (-50.1%) from their portfolio in Q2 2025, for an estimated $1,115,299,468
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 9,921,332 shares (+1556.4%) to their portfolio in Q2 2025, for an estimated $909,091,651
- PRICE T ROWE ASSOCIATES INC /MD/ removed 8,967,436 shares (-64.5%) from their portfolio in Q2 2025, for an estimated $821,686,160
- VIKING GLOBAL INVESTORS LP removed 5,344,064 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $524,199,237
- FMR LLC added 5,304,050 shares (+20.2%) to their portfolio in Q2 2025, for an estimated $486,010,101
- POLEN CAPITAL MANAGEMENT LLC added 4,535,178 shares (+88.3%) to their portfolio in Q2 2025, for an estimated $415,558,360
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
SBUX Analyst Ratings
Wall Street analysts have issued reports on $SBUX in the last several months. We have seen 13 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Baird issued a "Outperform" rating on 08/12/2025
- Barclays issued a "Overweight" rating on 07/30/2025
- JP Morgan issued a "Overweight" rating on 07/30/2025
- Piper Sandler issued a "Overweight" rating on 07/30/2025
- Morgan Stanley issued a "Overweight" rating on 07/30/2025
- BMO Capital issued a "Outperform" rating on 07/30/2025
- RBC Capital issued a "Outperform" rating on 07/30/2025
To track analyst ratings and price targets for SBUX, check out Quiver Quantitative's $SBUX forecast page.
SBUX Price Targets
Multiple analysts have issued price targets for $SBUX recently. We have seen 22 analysts offer price targets for $SBUX in the last 6 months, with a median target of $101.5.
Here are some recent targets:
- Andrew M. Charles from TD Cowen set a target price of $95.0 on 09/25/2025
- David Tarantino from Baird set a target price of $115.0 on 08/12/2025
- Gregory Francfort from Guggenheim set a target price of $90.0 on 07/31/2025
- John Ivankoe from JP Morgan set a target price of $105.0 on 07/30/2025
- Zachary Fadem from Wells Fargo set a target price of $105.0 on 07/30/2025
- Andrew Strelzik from BMO Capital set a target price of $115.0 on 07/30/2025
- Dennis Geiger from UBS set a target price of $100.0 on 07/30/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$22,500 of MAXIMUS lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues surrounding DOGE efforts and changes to federal staffing and contracting. Issues related to eligibility, verification and fraud."
You can find more data on corporate lobbying on Quiver Quantitative.
MMS Insider Trading Activity
MMS insiders have traded $MMS stock on the open market 6 times in the past 6 months. Of those trades, 5 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $MMS stock by insiders over the last 6 months:
- GAYATHRI RAJAN has made 2 purchases buying 124 shares for an estimated $9,609 and 1 sale selling 7,913 shares for an estimated $572,777.
- RAYMOND B RUDDY purchased 1,435 shares for an estimated $99,962
- MICHAEL J. WARREN has made 2 purchases buying 31 shares for an estimated $2,466 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
MMS Hedge Fund Activity
We have seen 196 institutional investors add shares of MMS stock to their portfolio, and 208 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JANUS HENDERSON GROUP PLC removed 415,501 shares (-43.9%) from their portfolio in Q2 2025, for an estimated $29,168,170
- SG CAPITAL MANAGEMENT LLC removed 405,689 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $27,663,932
- POINT72 ASSET MANAGEMENT, L.P. added 403,309 shares (+112.7%) to their portfolio in Q2 2025, for an estimated $28,312,291
- MAN GROUP PLC removed 395,345 shares (-95.9%) from their portfolio in Q2 2025, for an estimated $27,753,219
- MACKENZIE FINANCIAL CORP removed 284,973 shares (-10.2%) from their portfolio in Q2 2025, for an estimated $20,005,104
- NORGES BANK removed 274,902 shares (-28.7%) from their portfolio in Q2 2025, for an estimated $19,298,120
- BOSTON PARTNERS added 247,782 shares (+80.5%) to their portfolio in Q2 2025, for an estimated $17,394,296
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$2,310,000 of VISA INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues relating to digital payments including the cost of acceptance, interchange fees, payment card security, data security, and cybersecurity. Issues relating to fraud & ID theft. Issues relating to digital transformation and payments innovations. Issues relating to the Credit Card Competition Act Issues relating to merchant category codes. Issues relating to privacy and data use. Issues relating to stablecoin regulation. Issues relating to S. 394, the Guiding and Establishing National Innovation for U.S. Stablecoins (GENIUS) Act Issue relating to H.R. 2392, the Stablecoin Transparency and Accountability for a Better Ledger Economy (STABLE) Act Issues relating to artificial intelligence. Issues relating to cybersecurity. Issues relating to information sharing and cyber threats. Issues relating to payment network brand risk. Issues relating to domestic and international tax rules. Issue relating to the extension of corporate tax provisions included in TCJA 2017 including corporate rate, R&D incentives and GILTI/FDII rate. Issues relating to the deductibility of corporate state and local taxes. Issues relating to general international trade & sanctions issues. Issues relating to electronic payment services with China, Costa Rica, Brazil, Mexico, Central Asia and India. Issues relating to USMCA enforcement. Issues relating to U.S. tariffs. Issues relating to small business access to resources. Issues relating to workforce development. Issues relating to immigration."
You can find more data on corporate lobbying on Quiver Quantitative.
V Congressional Stock Trading
Members of Congress have traded $V stock 20 times in the past 6 months. Of those trades, 7 have been purchases and 13 have been sales.
Here’s a breakdown of recent trading of $V stock by members of Congress over the last 6 months:
- REPRESENTATIVE DAVID TAYLOR has traded it 2 times. They made 2 purchases worth up to $30,000 on 08/13 and 0 sales.
- REPRESENTATIVE JOSH GOTTHEIMER has traded it 7 times. They made 0 purchases and 7 sales worth up to $105,000 on 08/12, 08/01, 07/14, 06/26, 06/25, 06/24, 06/20.
- REPRESENTATIVE SCOTT FRANKLIN sold up to $50,000 on 06/16.
- REPRESENTATIVE JEFFERSON SHREVE has traded it 2 times. They made 0 purchases and 2 sales worth up to $300,000 on 05/12, 04/07.
- REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 05/05.
- REPRESENTATIVE BRUCE WESTERMAN sold up to $15,000 on 04/21.
- REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 04/11.
- REPRESENTATIVE BYRON DONALDS has traded it 2 times. They made 2 purchases worth up to $30,000 on 04/10 and 0 sales.
- REPRESENTATIVE ROBERT BRESNAHAN purchased up to $50,000 on 04/08.
- REPRESENTATIVE JARED MOSKOWITZ purchased up to $15,000 on 04/07.
- REPRESENTATIVE JULIE JOHNSON sold up to $50,000 on 04/07.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
V Insider Trading Activity
V insiders have traded $V stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.
Here’s a breakdown of recent trading of $V stock by insiders over the last 6 months:
- PAUL D FABARA (CHIEF RISK & CLIENT SVCS OFC) has made 0 purchases and 5 sales selling 90,333 shares for an estimated $33,038,002.
- RYAN MCINERNEY (Chief Executive Officer) has made 0 purchases and 6 sales selling 55,460 shares for an estimated $19,432,661.
- RAJAT TANEJA (PRESIDENT, TECHNOLOGY) has made 0 purchases and 2 sales selling 50,000 shares for an estimated $18,443,687.
- JULIE B ROTTENBERG (GENERAL COUNSEL) has made 0 purchases and 2 sales selling 4,602 shares for an estimated $1,587,197.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
V Hedge Fund Activity
We have seen 1,948 institutional investors add shares of V stock to their portfolio, and 2,074 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GAMMA INVESTING LLC removed 14,715,235 shares (-99.7%) from their portfolio in Q2 2025, for an estimated $5,224,644,186
- BARCLAYS PLC removed 3,974,532 shares (-33.1%) from their portfolio in Q2 2025, for an estimated $1,411,157,586
- JPMORGAN CHASE & CO removed 3,846,068 shares (-14.4%) from their portfolio in Q2 2025, for an estimated $1,365,546,443
- BLACKROCK, INC. removed 3,673,607 shares (-2.5%) from their portfolio in Q2 2025, for an estimated $1,304,314,165
- NORGES BANK added 3,451,229 shares (+21.1%) to their portfolio in Q2 2025, for an estimated $1,225,358,856
- DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN removed 2,877,551 shares (-83.0%) from their portfolio in Q2 2025, for an estimated $1,021,674,482
- VICTORY CAPITAL MANAGEMENT INC added 2,703,863 shares (+235.1%) to their portfolio in Q2 2025, for an estimated $960,006,558
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
V Analyst Ratings
Wall Street analysts have issued reports on $V in the last several months. We have seen 11 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Macquarie issued a "Outperform" rating on 07/31/2025
- Barclays issued a "Overweight" rating on 07/31/2025
- Morgan Stanley issued a "Overweight" rating on 07/30/2025
- UBS issued a "Buy" rating on 07/30/2025
- Deutsche Bank issued a "Buy" rating on 07/17/2025
- Truist Securities issued a "Buy" rating on 07/17/2025
- Oppenheimer issued a "Outperform" rating on 07/02/2025
To track analyst ratings and price targets for V, check out Quiver Quantitative's $V forecast page.
V Price Targets
Multiple analysts have issued price targets for $V recently. We have seen 12 analysts offer price targets for $V in the last 6 months, with a median target of $405.0.
Here are some recent targets:
- Paul Golding from Macquarie set a target price of $425.0 on 07/31/2025
- Raimo Lenschow from Barclays set a target price of $408.0 on 07/31/2025
- Timothy Chiodo from UBS set a target price of $415.0 on 07/30/2025
- James Faucette from Morgan Stanley set a target price of $402.0 on 07/30/2025
- Bryan Keane from Deutsche Bank set a target price of $410.0 on 07/17/2025
- Matthew Coad from Truist Securities set a target price of $397.0 on 07/17/2025
- Rayna Kumar from Oppenheimer set a target price of $391.0 on 07/02/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$50,000 of CAMECO CORPORATION lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Nuclear energy and uranium issues in federal legislation; U.S. nuclear enrichment policy; any policies or legislation regarding critical minerals; FY 26 Energy Appropriations bill. U.S. global energy security policy and related foreign policy matters;"
You can find more data on corporate lobbying on Quiver Quantitative.
CCJ Hedge Fund Activity
We have seen 406 institutional investors add shares of CCJ stock to their portfolio, and 435 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ALLIANCEBERNSTEIN L.P. removed 7,984,574 shares (-56.8%) from their portfolio in Q2 2025, for an estimated $592,694,928
- FIL LTD added 4,882,060 shares (+56.2%) to their portfolio in Q2 2025, for an estimated $362,395,313
- ARISTOTLE CAPITAL MANAGEMENT, LLC removed 2,334,086 shares (-52.1%) from their portfolio in Q2 2025, for an estimated $173,259,203
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 2,330,245 shares (-85.6%) from their portfolio in Q2 2025, for an estimated $172,974,086
- MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. removed 2,081,400 shares (-13.9%) from their portfolio in Q2 2025, for an estimated $154,502,322
- DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN added 2,071,373 shares (+41.4%) to their portfolio in Q2 2025, for an estimated $153,758,017
- FMR LLC added 1,567,804 shares (+10.6%) to their portfolio in Q2 2025, for an estimated $116,378,090
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CCJ Analyst Ratings
Wall Street analysts have issued reports on $CCJ in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- CLSA issued a "Outperform" rating on 09/09/2025
- RBC Capital issued a "Outperform" rating on 08/01/2025
- GLJ Research issued a "Buy" rating on 06/12/2025
- Goldman Sachs issued a "Buy" rating on 06/11/2025
To track analyst ratings and price targets for CCJ, check out Quiver Quantitative's $CCJ forecast page.
CCJ Price Targets
Multiple analysts have issued price targets for $CCJ recently. We have seen 4 analysts offer price targets for $CCJ in the last 6 months, with a median target of $90.0.
Here are some recent targets:
- Max Hopkins from CLSA set a target price of $102.0 on 09/09/2025
- Andrew Wong from RBC Capital set a target price of $110.0 on 08/01/2025
- Gordon Johnson from GLJ Research set a target price of $75.27 on 06/12/2025
- Brian Lee from Goldman Sachs set a target price of $78.0 on 06/11/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$40,000 of FORD MOTOR COMPANY lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"IIJA reauthorization, highway trust fund revenue sources, appropriations."
You can find more data on corporate lobbying on Quiver Quantitative.
F Congressional Stock Trading
Members of Congress have traded $F stock 9 times in the past 6 months. Of those trades, 7 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $F stock by members of Congress over the last 6 months:
- REPRESENTATIVE TIM MOORE has traded it 6 times. They made 5 purchases worth up to $300,000 on 04/10, 04/09, 04/08, 04/07, 03/31 and 1 sale worth up to $250,000 on 04/15.
- REPRESENTATIVE ROBERT BRESNAHAN purchased up to $15,000 on 04/08.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 04/01.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 03/31.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
F Insider Trading Activity
F insiders have traded $F stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $F stock by insiders over the last 6 months:
- ANDREW FRICK (President, Ford Blue & Model e) has made 0 purchases and 2 sales selling 60,000 shares for an estimated $675,000.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
F Hedge Fund Activity
We have seen 781 institutional investors add shares of F stock to their portfolio, and 862 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SQUAREPOINT OPS LLC added 25,213,900 shares (+2477.0%) to their portfolio in Q2 2025, for an estimated $273,570,815
- RENAISSANCE TECHNOLOGIES LLC added 24,143,142 shares (+124.8%) to their portfolio in Q2 2025, for an estimated $261,953,090
- BLACKROCK, INC. added 21,471,369 shares (+6.8%) to their portfolio in Q2 2025, for an estimated $232,964,353
- MARSHALL WACE, LLP added 17,164,234 shares (+712.7%) to their portfolio in Q2 2025, for an estimated $186,231,938
- GEODE CAPITAL MANAGEMENT, LLC added 15,748,694 shares (+17.9%) to their portfolio in Q2 2025, for an estimated $170,873,329
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 13,909,268 shares (-93.6%) from their portfolio in Q2 2025, for an estimated $150,915,557
- D. E. SHAW & CO., INC. removed 13,826,618 shares (-81.4%) from their portfolio in Q2 2025, for an estimated $150,018,805
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
F Analyst Ratings
Wall Street analysts have issued reports on $F in the last several months. We have seen 2 firms issue buy ratings on the stock, and 2 firms issue sell ratings.
Here are some recent analyst ratings:
- Jefferies issued a "Underperform" rating on 08/11/2025
- JP Morgan issued a "Overweight" rating on 07/21/2025
- B of A Securities issued a "Buy" rating on 04/22/2025
- Bernstein issued a "Underperform" rating on 04/09/2025
To track analyst ratings and price targets for F, check out Quiver Quantitative's $F forecast page.
F Price Targets
Multiple analysts have issued price targets for $F recently. We have seen 10 analysts offer price targets for $F in the last 6 months, with a median target of $11.0.
Here are some recent targets:
- Philippe Houchois from Jefferies set a target price of $9.0 on 08/11/2025
- Tom Narayan from RBC Capital set a target price of $11.0 on 08/05/2025
- Alexander Potter from Piper Sandler set a target price of $9.5 on 07/31/2025
- Ryan Brinkman from JP Morgan set a target price of $13.0 on 07/21/2025
- Dan Levy from Barclays set a target price of $11.0 on 07/16/2025
- Joseph Spak from UBS set a target price of $11.0 on 07/14/2025
- Michael Ward from Citigroup set a target price of $11.0 on 05/07/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$30,000 of FLUOR CORPORATION lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"IIJA reauthorization and appropriations"
You can find more data on corporate lobbying on Quiver Quantitative.
FLR Insider Trading Activity
FLR insiders have traded $FLR stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $FLR stock by insiders over the last 6 months:
- DAVID E CONSTABLE (Executive Chairman) has made 0 purchases and 3 sales selling 119,400 shares for an estimated $6,016,946.
- ALVIN C III COLLINS (GROUP PRESIDENT) has made 0 purchases and 2 sales selling 21,908 shares for an estimated $1,015,304.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
FLR Hedge Fund Activity
We have seen 267 institutional investors add shares of FLR stock to their portfolio, and 296 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- RUBRIC CAPITAL MANAGEMENT LP added 4,000,000 shares (+inf%) to their portfolio in Q2 2025, for an estimated $205,080,000
- DME CAPITAL MANAGEMENT, LP added 3,819,580 shares (+inf%) to their portfolio in Q2 2025, for an estimated $195,829,866
- ENCOMPASS CAPITAL ADVISORS LLC added 2,091,170 shares (+inf%) to their portfolio in Q2 2025, for an estimated $107,214,285
- SOURCEROCK GROUP LLC added 1,664,266 shares (+inf%) to their portfolio in Q2 2025, for an estimated $85,326,917
- MILLENNIUM MANAGEMENT LLC removed 1,315,765 shares (-41.0%) from their portfolio in Q2 2025, for an estimated $67,459,271
- TROLUCE CAPITAL ADVISORS LLC added 1,300,000 shares (+inf%) to their portfolio in Q2 2025, for an estimated $66,651,000
- SQUAREPOINT OPS LLC removed 1,202,623 shares (-78.8%) from their portfolio in Q2 2025, for an estimated $61,658,481
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
FLR Analyst Ratings
Wall Street analysts have issued reports on $FLR in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 08/06/2025
- Citigroup issued a "Buy" rating on 08/04/2025
- Truist Securities issued a "Buy" rating on 07/03/2025
To track analyst ratings and price targets for FLR, check out Quiver Quantitative's $FLR forecast page.
FLR Price Targets
Multiple analysts have issued price targets for $FLR recently. We have seen 5 analysts offer price targets for $FLR in the last 6 months, with a median target of $56.0.
Here are some recent targets:
- Steven Fisher from UBS set a target price of $56.0 on 08/06/2025
- Andrew Wittmann from Baird set a target price of $46.0 on 08/04/2025
- Andrew Kaplowitz from Citigroup set a target price of $57.0 on 08/04/2025
- Sangita Jain from Keybanc set a target price of $41.0 on 07/16/2025
- Jamie Cook from Truist Securities set a target price of $59.0 on 07/03/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$50,000 of QUALCOMM INCORPORATED lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"IIJA reauthorization and appropriations."
You can find more data on corporate lobbying on Quiver Quantitative.
QCOM Congressional Stock Trading
Members of Congress have traded $QCOM stock 7 times in the past 6 months. Of those trades, 4 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $QCOM stock by members of Congress over the last 6 months:
- REPRESENTATIVE RITCHIE TORRES sold up to $15,000 on 07/11.
- REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 3 times. They made 3 purchases worth up to $45,000 on 05/05, 04/08, 04/04 and 0 sales.
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 04/08.
- REPRESENTATIVE JARED MOSKOWITZ purchased up to $15,000 on 04/07.
- REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 04/07.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
QCOM Insider Trading Activity
QCOM insiders have traded $QCOM stock on the open market 39 times in the past 6 months. Of those trades, 0 have been purchases and 39 have been sales.
Here’s a breakdown of recent trading of $QCOM stock by insiders over the last 6 months:
- AKASH J. PALKHIWALA (CFO & COO) has made 0 purchases and 33 sales selling 19,998 shares for an estimated $2,953,393.
- HEATHER S ACE (Chief Human Resources Officer) has made 0 purchases and 2 sales selling 3,200 shares for an estimated $454,624.
- NEIL MARTIN (SVP, Finance and CAO) has made 0 purchases and 2 sales selling 1,577 shares for an estimated $243,270.
- PATRICIA Y GRECH (SVP & CAO) has made 0 purchases and 2 sales selling 509 shares for an estimated $81,440.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
QCOM Hedge Fund Activity
We have seen 1,268 institutional investors add shares of QCOM stock to their portfolio, and 1,421 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- KINGSTONE CAPITAL PARTNERS TEXAS, LLC added 58,764,593 shares (+656661.0%) to their portfolio in Q2 2025, for an estimated $9,358,849,081
- GAMMA INVESTING LLC removed 3,243,092 shares (-99.4%) from their portfolio in Q2 2025, for an estimated $516,494,831
- AMUNDI added 3,186,524 shares (+38.2%) to their portfolio in Q2 2025, for an estimated $507,485,812
- EDGEPOINT INVESTMENT GROUP INC. removed 3,082,396 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $473,486,849
- GEODE CAPITAL MANAGEMENT, LLC removed 2,953,700 shares (-10.3%) from their portfolio in Q2 2025, for an estimated $470,406,262
- FRANKLIN RESOURCES INC removed 2,569,660 shares (-28.1%) from their portfolio in Q2 2025, for an estimated $409,244,051
- BARCLAYS PLC added 2,131,007 shares (+34.4%) to their portfolio in Q2 2025, for an estimated $339,384,174
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
QCOM Analyst Ratings
Wall Street analysts have issued reports on $QCOM in the last several months. We have seen 8 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 07/31/2025
- Rosenblatt issued a "Buy" rating on 07/31/2025
- JP Morgan issued a "Overweight" rating on 07/28/2025
- B of A Securities issued a "Buy" rating on 06/17/2025
- Susquehanna issued a "Positive" rating on 05/01/2025
- Baird issued a "Outperform" rating on 05/01/2025
- Wells Fargo issued a "Underweight" rating on 05/01/2025
To track analyst ratings and price targets for QCOM, check out Quiver Quantitative's $QCOM forecast page.
QCOM Price Targets
Multiple analysts have issued price targets for $QCOM recently. We have seen 14 analysts offer price targets for $QCOM in the last 6 months, with a median target of $172.5.
Here are some recent targets:
- Harsh Kumar from Piper Sandler set a target price of $175.0 on 07/31/2025
- Kevin Cassidy from Rosenblatt set a target price of $225.0 on 07/31/2025
- Samik Chatterjee from JP Morgan set a target price of $200.0 on 07/28/2025
- Timothy Arcuri from UBS set a target price of $165.0 on 07/21/2025
- Christopher Danely from Citigroup set a target price of $170.0 on 07/07/2025
- Tal Liani from B of A Securities set a target price of $200.0 on 06/17/2025
- Mark Lipacis from Evercore ISI Group set a target price of $157.0 on 05/02/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$100,000 of OWENS CORNING lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Energy Efficiency - 25C Energy Efficient Home Tax Credit Energy Efficiency - 25C Energy Efficient Home Tax Credit Energy Efficiency - 25C Energy Efficient Home Tax Credit Tariffs AD/CVD Door Dumping"
You can find more data on corporate lobbying on Quiver Quantitative.
GLW Congressional Stock Trading
Members of Congress have traded $GLW stock 7 times in the past 6 months. Of those trades, 5 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $GLW stock by members of Congress over the last 6 months:
- REPRESENTATIVE JOSH GOTTHEIMER has traded it 4 times. They made 2 purchases worth up to $30,000 on 05/28, 05/22 and 2 sales worth up to $65,000 on 04/17, 04/09.
- REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 2 times. They made 2 purchases worth up to $30,000 on 05/14, 05/05 and 0 sales.
- REPRESENTATIVE ROBERT BRESNAHAN purchased up to $15,000 on 04/08.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
GLW Insider Trading Activity
GLW insiders have traded $GLW stock on the open market 18 times in the past 6 months. Of those trades, 0 have been purchases and 18 have been sales.
Here’s a breakdown of recent trading of $GLW stock by insiders over the last 6 months:
- WENDELL P WEEKS (Chairman and CEO) sold 82,103 shares for an estimated $5,351,933
- ERIC S MUSSER (President) has made 0 purchases and 4 sales selling 78,850 shares for an estimated $4,975,667.
- AVERY H III NELSON (Executive Vice President & COO) sold 36,240 shares for an estimated $2,256,356
- JAYMIN AMIN (SVP and Chief Tech. Officer) sold 17,721 shares for an estimated $1,367,697
- EDWARD A SCHLESINGER (Exec. Vice President and CFO) has made 0 purchases and 2 sales selling 18,546 shares for an estimated $1,099,546.
- SOUMYA SEETHARAM (Senior Vice President & CDIO) has made 0 purchases and 2 sales selling 20,818 shares for an estimated $1,041,082.
- LEWIS A STEVERSON (Vice Chairman, EVP and CLAO) sold 16,646 shares for an estimated $1,035,774
- JOHN Z ZHANG (Exec. Vice President & CCDO) has made 0 purchases and 3 sales selling 18,822 shares for an estimated $928,397.
- MICHAEL PAUL O'DAY (SVP and GM, Optical Comm.) sold 14,879 shares for an estimated $927,912
- MICHAEL ALAN BELL sold 20,262 shares for an estimated $892,768
- STEFAN BECKER (SVP, Finance & Corp Controller) sold 17,106 shares for an estimated $849,838
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
GLW Hedge Fund Activity
We have seen 760 institutional investors add shares of GLW stock to their portfolio, and 697 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ removed 6,167,585 shares (-36.3%) from their portfolio in Q2 2025, for an estimated $324,353,295
- WELLINGTON MANAGEMENT GROUP LLP removed 5,769,867 shares (-31.2%) from their portfolio in Q2 2025, for an estimated $303,437,305
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 4,669,886 shares (+inf%) to their portfolio in Q2 2025, for an estimated $245,589,304
- VICTORY CAPITAL MANAGEMENT INC added 3,441,557 shares (+561.8%) to their portfolio in Q2 2025, for an estimated $180,991,482
- PRIMECAP MANAGEMENT CO/CA/ removed 3,267,400 shares (-39.6%) from their portfolio in Q2 2025, for an estimated $171,832,566
- BANK OF AMERICA CORP /DE/ added 3,242,249 shares (+18.5%) to their portfolio in Q2 2025, for an estimated $170,509,874
- AMUNDI removed 2,967,324 shares (-46.3%) from their portfolio in Q2 2025, for an estimated $156,051,569
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
GLW Analyst Ratings
Wall Street analysts have issued reports on $GLW in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 09/02/2025
- Susquehanna issued a "Positive" rating on 07/30/2025
- Argus Research issued a "Buy" rating on 07/30/2025
- Oppenheimer issued a "Outperform" rating on 07/30/2025
- JP Morgan issued a "Overweight" rating on 07/25/2025
- Mizuho issued a "Outperform" rating on 07/15/2025
- Citigroup issued a "Buy" rating on 07/11/2025
To track analyst ratings and price targets for GLW, check out Quiver Quantitative's $GLW forecast page.
GLW Price Targets
Multiple analysts have issued price targets for $GLW recently. We have seen 9 analysts offer price targets for $GLW in the last 6 months, with a median target of $68.0.
Here are some recent targets:
- Joshua Spector from UBS set a target price of $84.0 on 09/02/2025
- John Roberts from Mizuho set a target price of $74.0 on 08/08/2025
- Martin Yang from Oppenheimer set a target price of $72.0 on 07/30/2025
- Meta Marshall from Morgan Stanley set a target price of $56.0 on 07/30/2025
- Tim Long from Barclays set a target price of $65.0 on 07/30/2025
- Jim Kelleher from Argus Research set a target price of $68.0 on 07/30/2025
- Mehdi Hosseini from Susquehanna set a target price of $75.0 on 07/30/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$30,000 of SOUTHWEST AIRLINES lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Explosive Detection Systems (EDS), Air Traffic Control (ATC) modernization, appropriations, and FAA reauthorization implementation."
You can find more data on corporate lobbying on Quiver Quantitative.
LUV Congressional Stock Trading
Members of Congress have traded $LUV stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $LUV stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $15,000 on 07/03 and 1 sale worth up to $15,000 on 08/05.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
LUV Insider Trading Activity
LUV insiders have traded $LUV stock on the open market 25 times in the past 6 months. Of those trades, 25 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $LUV stock by insiders over the last 6 months:
- PIERRE R BREBER has made 19 purchases buying 10,000 shares for an estimated $268,876 and 0 sales.
- GREGG A SARETSKY has made 3 purchases buying 7,015 shares for an estimated $200,616 and 0 sales.
- DAVID P HESS purchased 7,500 shares for an estimated $198,900
- SARAH FEINBERG has made 2 purchases buying 1,500 shares for an estimated $45,007 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
LUV Hedge Fund Activity
We have seen 338 institutional investors add shares of LUV stock to their portfolio, and 509 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG removed 11,353,191 shares (-52.4%) from their portfolio in Q2 2025, for an estimated $368,297,516
- NOMURA HOLDINGS INC added 10,463,417 shares (+953.3%) to their portfolio in Q2 2025, for an estimated $339,433,247
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 9,716,160 shares (+2403.8%) to their portfolio in Q2 2025, for an estimated $315,192,230
- MORGAN STANLEY removed 4,080,749 shares (-41.0%) from their portfolio in Q2 2025, for an estimated $132,379,497
- BLACKROCK, INC. removed 3,901,899 shares (-11.1%) from their portfolio in Q2 2025, for an estimated $126,577,603
- PRICE T ROWE ASSOCIATES INC /MD/ removed 3,681,605 shares (-16.1%) from their portfolio in Q2 2025, for an estimated $119,431,266
- CITADEL ADVISORS LLC removed 3,435,247 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $111,439,412
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
LUV Analyst Ratings
Wall Street analysts have issued reports on $LUV in the last several months. We have seen 1 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Raymond James issued a "Outperform" rating on 04/29/2025
- Citigroup issued a "Sell" rating on 04/14/2025
To track analyst ratings and price targets for LUV, check out Quiver Quantitative's $LUV forecast page.
LUV Price Targets
Multiple analysts have issued price targets for $LUV recently. We have seen 8 analysts offer price targets for $LUV in the last 6 months, with a median target of $34.0.
Here are some recent targets:
- Jamie Baker from JP Morgan set a target price of $35.0 on 09/12/2025
- Christopher Stathoulopoulos from Susquehanna set a target price of $30.0 on 08/05/2025
- Duane Pfennigwerth from Evercore ISI Group set a target price of $34.0 on 07/25/2025
- Brandon Oglenski from Barclays set a target price of $34.0 on 07/10/2025
- Thomas Wadewitz from UBS set a target price of $34.0 on 07/07/2025
- Sheila Kahyaoglu from Jefferies set a target price of $33.0 on 05/27/2025
- Savanthi Syth from Raymond James set a target price of $40.0 on 04/29/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$30,000 of BENTLEY SYSTEMS lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Surface transportation reauthorization and appropriations."
You can find more data on corporate lobbying on Quiver Quantitative.
BSY Insider Trading Activity
BSY insiders have traded $BSY stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales.
Here’s a breakdown of recent trading of $BSY stock by insiders over the last 6 months:
- RAYMOND B. BENTLEY has made 0 purchases and 5 sales selling 1,000,000 shares for an estimated $50,316,762.
- KEITH A. BENTLEY has made 0 purchases and 2 sales selling 150,000 shares for an estimated $8,330,510.
- DAVID R. SHAMAN (Chief Legal Officer) has made 0 purchases and 4 sales selling 39,869 shares for an estimated $2,233,942.
- GREGORY S BENTLEY (Executive Chair & President) sold 37,160 shares for an estimated $2,037,575
- BROCK BALLARD (Chief Revenue Officer) sold 12,363 shares for an estimated $557,269
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
BSY Hedge Fund Activity
We have seen 242 institutional investors add shares of BSY stock to their portfolio, and 255 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 4,393,181 shares (+31.6%) to their portfolio in Q2 2025, for an estimated $237,099,978
- MORGAN STANLEY added 2,876,840 shares (+223.4%) to their portfolio in Q2 2025, for an estimated $155,263,054
- BANK OF NEW YORK MELLON CORP added 2,066,725 shares (+207.6%) to their portfolio in Q2 2025, for an estimated $111,541,148
- MILLENNIUM MANAGEMENT LLC removed 1,474,372 shares (-90.5%) from their portfolio in Q2 2025, for an estimated $79,571,856
- VANGUARD GROUP INC removed 1,184,790 shares (-6.6%) from their portfolio in Q2 2025, for an estimated $63,943,116
- KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC removed 956,595 shares (-5.9%) from their portfolio in Q2 2025, for an estimated $51,627,432
- QUBE RESEARCH & TECHNOLOGIES LTD removed 927,404 shares (-90.4%) from their portfolio in Q2 2025, for an estimated $50,051,993
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BSY Analyst Ratings
Wall Street analysts have issued reports on $BSY in the last several months. We have seen 6 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 08/07/2025
- Goldman Sachs issued a "Sell" rating on 08/07/2025
- Oppenheimer issued a "Outperform" rating on 08/07/2025
- Baird issued a "Outperform" rating on 07/30/2025
- Keybanc issued a "Overweight" rating on 05/08/2025
- RBC Capital issued a "Outperform" rating on 05/08/2025
- Mizuho issued a "Outperform" rating on 04/15/2025
To track analyst ratings and price targets for BSY, check out Quiver Quantitative's $BSY forecast page.
BSY Price Targets
Multiple analysts have issued price targets for $BSY recently. We have seen 10 analysts offer price targets for $BSY in the last 6 months, with a median target of $58.5.
Here are some recent targets:
- Taylor McGinnis from UBS set a target price of $60.0 on 08/07/2025
- Blair Abernethy from Rosenblatt set a target price of $58.0 on 08/07/2025
- Kristen Owen from Oppenheimer set a target price of $65.0 on 08/07/2025
- Clarke Jeffries from Piper Sandler set a target price of $63.0 on 08/07/2025
- Kash Rangan from Goldman Sachs set a target price of $47.0 on 08/07/2025
- Joe Vruwink from Baird set a target price of $64.0 on 07/30/2025
- Jason Celino from Keybanc set a target price of $59.0 on 07/07/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$30,000 of ENVIRI CORPORATION (FORMERLY HARSCO CORPORATION) lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"IIJA reauthorization and appropriations"
You can find more data on corporate lobbying on Quiver Quantitative.
NVRI Hedge Fund Activity
We have seen 88 institutional investors add shares of NVRI stock to their portfolio, and 117 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FUND 1 INVESTMENTS, LLC added 3,483,315 shares (+94.4%) to their portfolio in Q2 2025, for an estimated $30,235,174
- ANGELO GORDON & CO., L.P. added 1,233,435 shares (+inf%) to their portfolio in Q2 2025, for an estimated $10,706,215
- INVESCO LTD. removed 1,016,307 shares (-52.8%) from their portfolio in Q2 2025, for an estimated $8,821,544
- NEWTYN MANAGEMENT, LLC added 1,001,018 shares (+inf%) to their portfolio in Q2 2025, for an estimated $8,688,836
- DIAMETER CAPITAL PARTNERS LP added 971,219 shares (+85.5%) to their portfolio in Q2 2025, for an estimated $8,430,180
- ROYAL BANK OF CANADA added 730,179 shares (+3091.4%) to their portfolio in Q2 2025, for an estimated $6,337,953
- 1060 CAPITAL, LLC added 645,670 shares (+inf%) to their portfolio in Q2 2025, for an estimated $5,604,415
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$10,000 of ANTERIX lobbying was just disclosed, from Q3 of 2024, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"None"
You can find more data on corporate lobbying on Quiver Quantitative.
ATEX Insider Trading Activity
ATEX insiders have traded $ATEX stock on the open market 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $ATEX stock by insiders over the last 6 months:
- WILLIAM HEARD sold 3,500 shares for an estimated $132,895
- SCOTT A. LANG (President and CEO) purchased 4,650 shares for an estimated $98,952
- TIMOTHY GRAY (Chief Financial Officer) purchased 50 shares for an estimated $1,103
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ATEX Hedge Fund Activity
We have seen 63 institutional investors add shares of ATEX stock to their portfolio, and 74 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- STONEHILL CAPITAL MANAGEMENT LLC removed 605,664 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $22,167,302
- DG CAPITAL MANAGEMENT, LLC added 213,626 shares (+33.2%) to their portfolio in Q2 2025, for an estimated $5,479,506
- ROUBAIX CAPITAL, LLC removed 161,706 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $4,147,758
- AYAL CAPITAL ADVISORS LTD added 141,500 shares (+143.4%) to their portfolio in Q2 2025, for an estimated $3,629,475
- BLACKROCK, INC. added 138,988 shares (+13.9%) to their portfolio in Q2 2025, for an estimated $3,565,042
- GAMCO INVESTORS, INC. ET AL added 70,855 shares (+35.0%) to their portfolio in Q2 2025, for an estimated $1,817,430
- MARSHALL WACE, LLP added 63,983 shares (+51.2%) to their portfolio in Q2 2025, for an estimated $1,641,163
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$614,723 of PRUDENTIAL FINANCIAL INC lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"SEC Best Interest Standard Expanding Access to Capital Act Capital Markets efficiency 403B parity (HR 1013/S 424) E-delivery: Improving Disclosure for Investors Act Protected Lifetime Income Paid Family Leave Tax Credit Paid Family Leave Tax Credit (H.R. 996, S. 400) Ordinary tax treatment of bonds Tax treatment of state and local taxes Tax treatment of life insurance and annuities International Tax (GILTI, Pillar 2) Data Security, AI, Privacy and Breach Legislation Paid Family Leave"
You can find more data on corporate lobbying on Quiver Quantitative.
PRU Congressional Stock Trading
Members of Congress have traded $PRU stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $PRU stock by members of Congress over the last 6 months:
- REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 05/12.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
PRU Insider Trading Activity
PRU insiders have traded $PRU stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $PRU stock by insiders over the last 6 months:
- ANN M KAPPLER (EVP and General Counsel) sold 4,000 shares for an estimated $438,600
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
PRU Hedge Fund Activity
We have seen 617 institutional investors add shares of PRU stock to their portfolio, and 683 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AMERIPRISE FINANCIAL INC removed 1,380,493 shares (-76.6%) from their portfolio in Q2 2025, for an estimated $148,320,167
- GAMMA INVESTING LLC removed 859,857 shares (-99.1%) from their portfolio in Q2 2025, for an estimated $92,383,036
- BLACKROCK, INC. removed 745,755 shares (-2.3%) from their portfolio in Q2 2025, for an estimated $80,123,917
- VANGUARD GROUP INC added 600,482 shares (+1.4%) to their portfolio in Q2 2025, for an estimated $64,515,786
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 592,857 shares (+17.5%) to their portfolio in Q2 2025, for an estimated $63,696,556
- GOLDMAN SACHS GROUP INC removed 588,528 shares (-14.0%) from their portfolio in Q2 2025, for an estimated $63,231,448
- NORDEA INVESTMENT MANAGEMENT AB added 567,571 shares (+49.2%) to their portfolio in Q2 2025, for an estimated $60,979,828
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
PRU Price Targets
Multiple analysts have issued price targets for $PRU recently. We have seen 7 analysts offer price targets for $PRU in the last 6 months, with a median target of $117.0.
Here are some recent targets:
- Nigel Dally from Morgan Stanley set a target price of $117.0 on 08/18/2025
- Alex Scott from Barclays set a target price of $120.0 on 07/17/2025
- Elyse Greenspan from Wells Fargo set a target price of $113.0 on 07/16/2025
- John Barnidge from Piper Sandler set a target price of $108.0 on 07/16/2025
- Jimmy Bhullar from JP Morgan set a target price of $136.0 on 07/08/2025
- Brian Meredith from UBS set a target price of $110.0 on 05/27/2025
- Ryan Krueger from Keefe, Bruyette & Woods set a target price of $117.0 on 05/07/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$40,000 of FEDEX CORPORATION lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Monitor implementation of the FAA Reauthorization of 2024 (P.L. 118-63) as it pertains to airport infrastructure funding, U.S. EU Open Skies Agreement, aviation safety, and sustainable aviation fuel (SAF) investments. Issues related to labor competition and recruitment in the airline and trucking industry. Monitor trucking legislation. Monitor trucking legislation related to parking and automated technology. General monitoring of U.S. foreign relations and international trade; monitoring of U.S.-China relations. Issues related to the National Cybersecurity Strategy. Monitor policies related to the Executive Order on Artificial Intelligence (AI). Monitor the legislative activity related to reconciliation and H.R.1, the One Big Beautiful Bill Act, and legislative and regulatory actions related to tax."
You can find more data on corporate lobbying on Quiver Quantitative.
FDX Congressional Stock Trading
Members of Congress have traded $FDX stock 7 times in the past 6 months. Of those trades, 5 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $FDX stock by members of Congress over the last 6 months:
- REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 5 times. They made 5 purchases worth up to $110,000 on 08/28, 05/05, 04/08, 04/04, 04/03 and 0 sales.
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 04/08.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 04/01.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
FDX Insider Trading Activity
FDX insiders have traded $FDX stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $FDX stock by insiders over the last 6 months:
- FREDERICK W SMITH (Executive Chairman) has made 0 purchases and 4 sales selling 123,850 shares for an estimated $25,122,520.
- JOHN ALAN SMITH (COO - US&CAN FEC) has made 0 purchases and 2 sales selling 6,155 shares for an estimated $1,499,050.
- GINA F. ADAMS (EVP GENL COUNSEL/SECTY) sold 4,770 shares for an estimated $1,153,624
- PAUL S WALSH sold 3,610 shares for an estimated $860,240
- MARVIN R ELLISON sold 3,610 shares for an estimated $855,353
- JOSHUA COOPER RAMO sold 3,610 shares for an estimated $838,361
- R BRAD MARTIN sold 2,123 shares for an estimated $513,235
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
FDX Hedge Fund Activity
We have seen 725 institutional investors add shares of FDX stock to their portfolio, and 996 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VALEO FINANCIAL ADVISORS, LLC added 3,730,273 shares (+28080.9%) to their portfolio in Q2 2025, for an estimated $847,928,355
- MAWER INVESTMENT MANAGEMENT LTD. removed 2,274,767 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $517,077,286
- CAPITAL INTERNATIONAL INVESTORS removed 2,131,722 shares (-22.1%) from their portfolio in Q2 2025, for an estimated $484,561,727
- PRIMECAP MANAGEMENT CO/CA/ removed 1,840,460 shares (-15.4%) from their portfolio in Q2 2025, for an estimated $418,354,962
- BLACKROCK, INC. added 1,087,729 shares (+6.6%) to their portfolio in Q2 2025, for an estimated $247,251,678
- FMR LLC added 912,322 shares (+60.7%) to their portfolio in Q2 2025, for an estimated $207,379,913
- AQR CAPITAL MANAGEMENT LLC added 896,271 shares (+750.9%) to their portfolio in Q2 2025, for an estimated $203,731,361
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
FDX Analyst Ratings
Wall Street analysts have issued reports on $FDX in the last several months. We have seen 11 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 08/28/2025
- Citigroup issued a "Buy" rating on 08/18/2025
- Barclays issued a "Overweight" rating on 06/25/2025
- Truist Securities issued a "Buy" rating on 06/25/2025
- Susquehanna issued a "Positive" rating on 06/25/2025
- Stifel issued a "Buy" rating on 06/25/2025
- Raymond James issued a "Outperform" rating on 06/25/2025
To track analyst ratings and price targets for FDX, check out Quiver Quantitative's $FDX forecast page.
FDX Price Targets
Multiple analysts have issued price targets for $FDX recently. We have seen 16 analysts offer price targets for $FDX in the last 6 months, with a median target of $275.0.
Here are some recent targets:
- Jonathan Chappell from Evercore ISI Group set a target price of $243.0 on 09/17/2025
- David Vernon from Bernstein set a target price of $247.0 on 09/16/2025
- Ken Hoexter from B of A Securities set a target price of $240.0 on 09/11/2025
- Brian Ossenbeck from JP Morgan set a target price of $285.0 on 09/05/2025
- Thomas Wadewitz from UBS set a target price of $293.0 on 08/28/2025
- Ariel Rosa from Citigroup set a target price of $275.0 on 08/18/2025
- Christian Wetherbee from Wells Fargo set a target price of $235.0 on 06/25/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$900,000 of CORTEVA AGRISCIENCE LLC (FKA E I DU PONT DE NEMOURS AND COMPANY) lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Implementation and oversight of the Agriculture Marketing Act of 1946 to require the Secretary of Proposed update to plant incorporated protectant rule and proposed update to guidance clarifying the regulatory approach for food from plantsdeveloped with the newest tools of genome editing. 7CFR Part 340 Pesticide Matters Seed Matters Climate change matters 2024 Farm Bill Endangered Species Act and Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) Biostimulant regulatory matters Pesticide matters Farm Bill 2024 Endangered Species Act and Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) Pesticide matters Climate change matters Trade Intellectual property rights and protection Agriculture trade Trade and international relations Tariff matters Seed trade matters Issues related to Mexico's regulation of agricultural biotechnology and pesticides Corporate taxation matters Taxation matters impacting US farmers 2025 NDAA Intellectual property rights and protection Technology access"
You can find more data on corporate lobbying on Quiver Quantitative.
CTVA Insider Trading Activity
CTVA insiders have traded $CTVA stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $CTVA stock by insiders over the last 6 months:
- CORNEL B FUERER (See Remarks) sold 55,242 shares for an estimated $3,759,770
- ROBERT D. KING (EVP, Crop Protection Business) sold 37,280 shares for an estimated $2,765,993
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CTVA Hedge Fund Activity
We have seen 657 institutional investors add shares of CTVA stock to their portfolio, and 624 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- HARRIS ASSOCIATES L P removed 6,043,980 shares (-46.7%) from their portfolio in Q2 2025, for an estimated $450,457,829
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 5,332,353 shares (-43.2%) from their portfolio in Q2 2025, for an estimated $397,420,269
- FMR LLC added 4,777,344 shares (+52.8%) to their portfolio in Q2 2025, for an estimated $356,055,448
- CAPITAL WORLD INVESTORS added 3,934,636 shares (+20.4%) to their portfolio in Q2 2025, for an estimated $293,248,421
- VAN ECK ASSOCIATES CORP removed 3,775,701 shares (-43.9%) from their portfolio in Q2 2025, for an estimated $281,402,995
- INDEPENDENT FRANCHISE PARTNERS LLP removed 3,389,825 shares (-20.2%) from their portfolio in Q2 2025, for an estimated $252,643,657
- VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. removed 2,731,022 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $171,863,214
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CTVA Analyst Ratings
Wall Street analysts have issued reports on $CTVA in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 08/08/2025
- Keybanc issued a "Overweight" rating on 08/08/2025
- UBS issued a "Buy" rating on 08/07/2025
- BMO Capital issued a "Outperform" rating on 07/08/2025
- Jefferies issued a "Buy" rating on 06/06/2025
- Citigroup issued a "Buy" rating on 05/09/2025
- Morgan Stanley issued a "Overweight" rating on 05/09/2025
To track analyst ratings and price targets for CTVA, check out Quiver Quantitative's $CTVA forecast page.
CTVA Price Targets
Multiple analysts have issued price targets for $CTVA recently. We have seen 12 analysts offer price targets for $CTVA in the last 6 months, with a median target of $84.5.
Here are some recent targets:
- Benjamin Theurer from Barclays set a target price of $84.0 on 08/13/2025
- Richard Garchitorena from Wells Fargo set a target price of $83.0 on 08/08/2025
- Aleksey Yefremov from Keybanc set a target price of $85.0 on 08/08/2025
- Joshua Spector from UBS set a target price of $91.0 on 08/07/2025
- Kristen Owen from Oppenheimer set a target price of $87.0 on 07/15/2025
- Arun Viswanathan from RBC Capital set a target price of $85.0 on 07/10/2025
- Joel Jackson from BMO Capital set a target price of $86.0 on 07/08/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$40,000 of ANHEUSER-BUSCH COMPANIES lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"IP infringement and rule-of-law issues in Mexico."
You can find more data on corporate lobbying on Quiver Quantitative.
BUD Congressional Stock Trading
Members of Congress have traded $BUD stock 5 times in the past 6 months. Of those trades, 2 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $BUD stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 4 times. They made 2 purchases worth up to $30,000 on 07/16, 06/09 and 2 sales worth up to $30,000 on 08/04, 06/11.
- REPRESENTATIVE BRUCE WESTERMAN sold up to $15,000 on 04/21.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
BUD Hedge Fund Activity
We have seen 246 institutional investors add shares of BUD stock to their portfolio, and 282 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 5,405,244 shares (+348.6%) to their portfolio in Q2 2025, for an estimated $371,448,367
- DODGE & COX removed 2,638,596 shares (-6.4%) from their portfolio in Q2 2025, for an estimated $181,324,317
- ROYAL BANK OF CANADA removed 1,920,047 shares (-48.6%) from their portfolio in Q2 2025, for an estimated $131,945,629
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC removed 1,559,800 shares (-55.9%) from their portfolio in Q2 2025, for an estimated $107,189,456
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 1,361,743 shares (-74.9%) from their portfolio in Q2 2025, for an estimated $93,578,978
- ARMISTICE CAPITAL, LLC removed 1,359,000 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $83,660,040
- RIVULET CAPITAL, LLC removed 1,115,250 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $68,654,790
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BUD Analyst Ratings
Wall Street analysts have issued reports on $BUD in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Goldman Sachs issued a "Buy" rating on 05/12/2025
To track analyst ratings and price targets for BUD, check out Quiver Quantitative's $BUD forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$3,890,000 of LOCKHEED MARTIN CORPORATION lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"HR 1 - One Big Beautiful Bill Act, Title II, including issues related to aircraft, space programs, intelligence programs, missile programs, maritime programs, tax programs, Research Design Test and Evaluation (RDTE), procurement, munitions programs, rotary wing aviation, border protection programs; S (not yet introduced)/HR 4016 - Department of Defense Appropriations Act, 2026 including issues related to aircraft, space programs, intelligence programs, missile programs, maritime programs, RDTE, procurement, munition programs, helicopters, radars, sensors, directed energy programs; S (not yet introduced)/HR (not yet introduced) - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 including issues related to aircraft, space programs, acquisition; S (not yet introduced)/HR (not yet introduced) - Interior, Environment, and Related Agencies Subcommittee, 2026 including issues related to forest service technology HR 1 - One Big Beautiful Bill Act, Title II, including issues related to aircraft, spectrum, space programs, missiles, missile defense, technology development, intelligence programs, maritime programs, tax programs, defense funding; S (2296)/HR (3838) - National Defense Authorization Act for Fiscal Year 2026 including issues related to electromagnetic spectrum, acquisition policy, space programs, missiles, missile defense, technology development, aircraft, RDTE, procurement, munitions, helicopters, radars, sensors, directed energy programs; S (not yet introduced)/HR 4016 - Department of Defense Appropriations Act, 2026 including issues related to aircraft, space programs, missiles, missile defense, technology development, maritime programs, intelligence programs, helicopters; S 5618 - FoRGED Act including issues related to acquisition policy HR 1 - One Big Beautiful Bill Act including issues related to aircraft, space programs, intelligence programs, missile programs, maritime programs, tax programs; S (not yet introduced)/HR (not yet introduced) - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 including issues related aircraft, space programs, acquisition; S (not yet introduced)/HR 4016 - Department of Defense Appropriations Act, 2026 including issues related to aircraft, space programs, intelligence programs, missile programs, maritime programs S (not yet introduced)/HR (not yet introduced) - Interior, Environment, and Related Agencies Subcommittee, 2026 including issues related to wildfire technology, firefighting intelligence HR 1 - One Big Beautiful Bill Act including issues related research and development, foreign-derived intangible income, health savings account issues, healthcare taxation; S 1639/HR 1990 - American Innovation and Jobs Act including issues related to research and development amortization HR 3613 - Streamlining Foreign Military Sales Act of 2025 including issues related to foreign military sales reform S (not yet introduced)/HR (not yet introduced) - Intelligence Authorization Act for 2026 including issues related to classified intelligence matters"
You can find more data on corporate lobbying on Quiver Quantitative.
LMT Congressional Stock Trading
Members of Congress have traded $LMT stock 8 times in the past 6 months. Of those trades, 4 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $LMT stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 2 purchases worth up to $30,000 on 08/05, 04/29 and 1 sale worth up to $15,000 on 05/30.
- REPRESENTATIVE JEFFERSON SHREVE has traded it 2 times. They made 1 purchase worth up to $50,000 on 04/11 and 1 sale worth up to $50,000 on 05/12.
- REPRESENTATIVE JARED MOSKOWITZ purchased up to $15,000 on 04/07.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 04/01.
- REPRESENTATIVE GEORGE WHITESIDES sold up to $100,000 on 03/24.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
LMT Hedge Fund Activity
We have seen 1,223 institutional investors add shares of LMT stock to their portfolio, and 1,257 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GAMMA INVESTING LLC removed 1,985,876 shares (-99.7%) from their portfolio in Q2 2025, for an estimated $919,738,610
- TABLEAUX LLC added 621,300 shares (+34231.4%) to their portfolio in Q2 2025, for an estimated $287,748,882
- DEMARS FINANCIAL GROUP, LLC removed 392,478 shares (-99.8%) from their portfolio in Q2 2025, for an estimated $181,772,260
- FIRST TRUST ADVISORS LP removed 382,969 shares (-74.6%) from their portfolio in Q2 2025, for an estimated $177,368,262
- MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. added 359,748 shares (+169.3%) to their portfolio in Q2 2025, for an estimated $166,613,688
- BLACKROCK, INC. added 352,765 shares (+2.1%) to their portfolio in Q2 2025, for an estimated $163,379,582
- MORGAN STANLEY added 330,891 shares (+6.6%) to their portfolio in Q2 2025, for an estimated $153,248,857
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
LMT Analyst Ratings
Wall Street analysts have issued reports on $LMT in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Baird issued a "Outperform" rating on 07/23/2025
- Susquehanna issued a "Positive" rating on 07/23/2025
- Truist Securities issued a "Buy" rating on 07/11/2025
To track analyst ratings and price targets for LMT, check out Quiver Quantitative's $LMT forecast page.
LMT Price Targets
Multiple analysts have issued price targets for $LMT recently. We have seen 9 analysts offer price targets for $LMT in the last 6 months, with a median target of $465.0.
Here are some recent targets:
- Ronald Epstein from B of A Securities set a target price of $480.0 on 08/21/2025
- Peter Arment from Baird set a target price of $500.0 on 07/23/2025
- Seth Seifman from JP Morgan set a target price of $465.0 on 07/23/2025
- Michael Ciarmoli from Truist Securities set a target price of $440.0 on 07/23/2025
- Gavin Parsons from UBS set a target price of $453.0 on 07/23/2025
- Ken Herbert from RBC Capital set a target price of $440.0 on 07/23/2025
- Charles Minervino from Susquehanna set a target price of $490.0 on 07/23/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$825,887 of FLUOR CORPORATION lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to ongoing transportation projects. Issues related to Implementation of the Infrastructure Investment and Jobs Act, P.L. 117-58. Issues related to authorization of Surface Transportation Act. Issues related to ongoing management of DOE projects. Issues related to construction of commercial energy operations, as well as DOE grant and loan guarantee programs. Issues related to domestic & international energy projects. Issues related to SMR development. Issues related to funding of DOD, DOE, DOT and DHS programs in the Continuing Appropriations and Extensions Act, 2025 --HR 1968. P.L. 119-4. Issues related to FY26 Energy and Water Appropriations. Issues related to DOD contingency operations and support services--FY 2026 National Defense Authorization Act (NDAA). Monitored issues related to LOGCAP and AFCAP. Issues related to AUKUS and associated projects in Australia. CHIPS projects related to funding and policy--Building Chips in America Act--S2228, P.L. 118-105. Issues related to overseas projects and operations. Issues related to management of FEMA Operations, Disaster Recovery, and declarations. Issues related to global emissions reporting standards."
You can find more data on corporate lobbying on Quiver Quantitative.
FLR Insider Trading Activity
FLR insiders have traded $FLR stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $FLR stock by insiders over the last 6 months:
- DAVID E CONSTABLE (Executive Chairman) has made 0 purchases and 3 sales selling 119,400 shares for an estimated $6,016,946.
- ALVIN C III COLLINS (GROUP PRESIDENT) has made 0 purchases and 2 sales selling 21,908 shares for an estimated $1,015,304.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
FLR Hedge Fund Activity
We have seen 267 institutional investors add shares of FLR stock to their portfolio, and 296 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- RUBRIC CAPITAL MANAGEMENT LP added 4,000,000 shares (+inf%) to their portfolio in Q2 2025, for an estimated $205,080,000
- DME CAPITAL MANAGEMENT, LP added 3,819,580 shares (+inf%) to their portfolio in Q2 2025, for an estimated $195,829,866
- ENCOMPASS CAPITAL ADVISORS LLC added 2,091,170 shares (+inf%) to their portfolio in Q2 2025, for an estimated $107,214,285
- SOURCEROCK GROUP LLC added 1,664,266 shares (+inf%) to their portfolio in Q2 2025, for an estimated $85,326,917
- MILLENNIUM MANAGEMENT LLC removed 1,315,765 shares (-41.0%) from their portfolio in Q2 2025, for an estimated $67,459,271
- TROLUCE CAPITAL ADVISORS LLC added 1,300,000 shares (+inf%) to their portfolio in Q2 2025, for an estimated $66,651,000
- SQUAREPOINT OPS LLC removed 1,202,623 shares (-78.8%) from their portfolio in Q2 2025, for an estimated $61,658,481
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
FLR Analyst Ratings
Wall Street analysts have issued reports on $FLR in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 08/06/2025
- Citigroup issued a "Buy" rating on 08/04/2025
- Truist Securities issued a "Buy" rating on 07/03/2025
To track analyst ratings and price targets for FLR, check out Quiver Quantitative's $FLR forecast page.
FLR Price Targets
Multiple analysts have issued price targets for $FLR recently. We have seen 5 analysts offer price targets for $FLR in the last 6 months, with a median target of $56.0.
Here are some recent targets:
- Steven Fisher from UBS set a target price of $56.0 on 08/06/2025
- Andrew Kaplowitz from Citigroup set a target price of $57.0 on 08/04/2025
- Andrew Wittmann from Baird set a target price of $46.0 on 08/04/2025
- Sangita Jain from Keybanc set a target price of $41.0 on 07/16/2025
- Jamie Cook from Truist Securities set a target price of $59.0 on 07/03/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$620,000 of ARDELYX INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Medicare, ESRD Bundle, H.R.5074, S.4510, Kidney Patient Act"
You can find more data on corporate lobbying on Quiver Quantitative.
ARDX Insider Trading Activity
ARDX insiders have traded $ARDX stock on the open market 20 times in the past 6 months. Of those trades, 4 have been purchases and 16 have been sales.
Here’s a breakdown of recent trading of $ARDX stock by insiders over the last 6 months:
- DAVID M MOTT has made 4 purchases buying 881,377 shares for an estimated $3,403,196 and 0 sales.
- MICHAEL RAAB (President & CEO) has made 0 purchases and 4 sales selling 175,836 shares for an estimated $830,399.
- LAURA A WILLIAMS (Chief Patient Officer) has made 0 purchases and 4 sales selling 92,682 shares for an estimated $553,025.
- ERIC DUANE FOSTER (Chief Commercial Officer) has made 0 purchases and 2 sales selling 17,815 shares for an estimated $101,034.
- MIKE KELLIHER (Chief Business Officer) has made 0 purchases and 2 sales selling 19,939 shares for an estimated $91,402.
- JUSTIN A RENZ (Chief Financial Officer) has made 0 purchases and 2 sales selling 14,255 shares for an estimated $71,200.
- ELIZABETH A GRAMMER (See Remarks) has made 0 purchases and 2 sales selling 11,833 shares for an estimated $59,102.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ARDX Hedge Fund Activity
We have seen 107 institutional investors add shares of ARDX stock to their portfolio, and 131 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JANUS HENDERSON GROUP PLC removed 9,919,066 shares (-39.7%) from their portfolio in Q2 2025, for an estimated $38,882,738
- EVENTIDE ASSET MANAGEMENT, LLC removed 5,600,764 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $27,499,751
- MILLENNIUM MANAGEMENT LLC added 5,197,967 shares (+80.4%) to their portfolio in Q2 2025, for an estimated $20,376,030
- MARSHALL WACE, LLP added 2,866,843 shares (+34.2%) to their portfolio in Q2 2025, for an estimated $11,238,024
- BLACKROCK, INC. added 2,799,200 shares (+15.6%) to their portfolio in Q2 2025, for an estimated $10,972,864
- BANK OF AMERICA CORP /DE/ added 2,600,080 shares (+88.8%) to their portfolio in Q2 2025, for an estimated $10,192,313
- JONES FINANCIAL COMPANIES LLLP added 1,832,320 shares (+16861.3%) to their portfolio in Q2 2025, for an estimated $7,182,694
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ARDX Analyst Ratings
Wall Street analysts have issued reports on $ARDX in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 06/18/2025
- Citigroup issued a "Buy" rating on 05/02/2025
To track analyst ratings and price targets for ARDX, check out Quiver Quantitative's $ARDX forecast page.
ARDX Price Targets
Multiple analysts have issued price targets for $ARDX recently. We have seen 5 analysts offer price targets for $ARDX in the last 6 months, with a median target of $10.0.
Here are some recent targets:
- Christopher Raymond from Piper Sandler set a target price of $9.0 on 08/06/2025
- Laura Chico from Wedbush set a target price of $14.0 on 08/05/2025
- Ryan Deschner from Raymond James set a target price of $12.0 on 08/05/2025
- Matthew Caufield from HC Wainwright & Co. set a target price of $10.0 on 06/18/2025
- Yigal Nochomovitz from Citigroup set a target price of $10.0 on 05/02/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$130,000 of AEROVIRONMENT INC. lobbying was just disclosed, from Q3 of 2024, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"FY25 Defense Authorization and Appropriations."
You can find more data on corporate lobbying on Quiver Quantitative.
AVAV Insider Trading Activity
AVAV insiders have traded $AVAV stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $AVAV stock by insiders over the last 6 months:
- WAHID NAWABI (Chair, President and CEO) has made 0 purchases and 2 sales selling 46,666 shares for an estimated $8,315,486.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
AVAV Hedge Fund Activity
We have seen 294 institutional investors add shares of AVAV stock to their portfolio, and 217 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VANGUARD GROUP INC added 433,830 shares (+14.3%) to their portfolio in Q2 2025, for an estimated $123,619,858
- ALYESKA INVESTMENT GROUP, L.P. removed 415,203 shares (-46.0%) from their portfolio in Q2 2025, for an estimated $118,312,094
- POINT72 ASSET MANAGEMENT, L.P. removed 383,659 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $109,323,632
- DRIEHAUS CAPITAL MANAGEMENT LLC added 293,860 shares (+inf%) to their portfolio in Q2 2025, for an estimated $83,735,407
- HEARD CAPITAL LLC removed 286,347 shares (-34.1%) from their portfolio in Q2 2025, for an estimated $81,594,577
- INVESCO LTD. added 262,239 shares (+75.6%) to their portfolio in Q2 2025, for an estimated $74,725,003
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 258,934 shares (+inf%) to their portfolio in Q2 2025, for an estimated $73,783,243
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
AVAV Analyst Ratings
Wall Street analysts have issued reports on $AVAV in the last several months. We have seen 10 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 09/11/2025
- Needham issued a "Buy" rating on 09/10/2025
- JMP Securities issued a "Market Outperform" rating on 08/18/2025
- Canaccord Genuity issued a "Buy" rating on 08/11/2025
- Baird issued a "Outperform" rating on 08/04/2025
- RBC Capital issued a "Outperform" rating on 07/17/2025
- Jefferies issued a "Buy" rating on 07/02/2025
To track analyst ratings and price targets for AVAV, check out Quiver Quantitative's $AVAV forecast page.
AVAV Price Targets
Multiple analysts have issued price targets for $AVAV recently. We have seen 12 analysts offer price targets for $AVAV in the last 6 months, with a median target of $300.0.
Here are some recent targets:
- Andre Madrid from BTIG set a target price of $300.0 on 09/11/2025
- Austin Bohlig from Needham set a target price of $300.0 on 09/10/2025
- Trevor Walsh from JMP Securities set a target price of $325.0 on 08/18/2025
- Austin Moeller from Canaccord Genuity set a target price of $305.0 on 08/11/2025
- Peter Arment from Baird set a target price of $267.0 on 08/04/2025
- Kevin Liu from RBC Capital set a target price of $300.0 on 07/17/2025
- Colin Canfield from Cantor Fitzgerald set a target price of $335.0 on 07/08/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$60,000 of KILROY REALTY lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"VISN 21 VA facilities modernization Marine Corps Air Station Miramar flight regulations Corporate State and Local Tax Deduction"
You can find more data on corporate lobbying on Quiver Quantitative.
KRC Hedge Fund Activity
We have seen 174 institutional investors add shares of KRC stock to their portfolio, and 208 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- COHEN & STEERS, INC. added 10,249,689 shares (+158.7%) to their portfolio in Q2 2025, for an estimated $351,666,829
- DAIWA SECURITIES GROUP INC. added 2,236,539 shares (+168.6%) to their portfolio in Q2 2025, for an estimated $76,735,653
- FMR LLC removed 1,502,396 shares (-25.6%) from their portfolio in Q2 2025, for an estimated $51,547,206
- BLACKROCK, INC. added 1,148,713 shares (+7.8%) to their portfolio in Q2 2025, for an estimated $39,412,343
- CANADA PENSION PLAN INVESTMENT BOARD removed 1,035,000 shares (-26.7%) from their portfolio in Q2 2025, for an estimated $35,510,850
- ROUTE ONE INVESTMENT COMPANY, L.P. added 1,000,900 shares (+inf%) to their portfolio in Q2 2025, for an estimated $34,340,879
- SCHRODER INVESTMENT MANAGEMENT GROUP removed 993,096 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $34,073,123
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
KRC Analyst Ratings
Wall Street analysts have issued reports on $KRC in the last several months. We have seen 2 firms issue buy ratings on the stock, and 2 firms issue sell ratings.
Here are some recent analyst ratings:
- Scotiabank issued a "Sector Underperform" rating on 08/28/2025
- Goldman Sachs issued a "Sell" rating on 08/21/2025
- JP Morgan issued a "Overweight" rating on 07/02/2025
- Keybanc issued a "Overweight" rating on 03/31/2025
To track analyst ratings and price targets for KRC, check out Quiver Quantitative's $KRC forecast page.
KRC Price Targets
Multiple analysts have issued price targets for $KRC recently. We have seen 10 analysts offer price targets for $KRC in the last 6 months, with a median target of $40.0.
Here are some recent targets:
- Steve Sakwa from Evercore ISI Group set a target price of $46.0 on 09/08/2025
- Brendan Lynch from Barclays set a target price of $43.0 on 09/04/2025
- Nicholas Yulico from Scotiabank set a target price of $40.0 on 08/28/2025
- Blaine Heck from Wells Fargo set a target price of $40.0 on 08/27/2025
- Caitlin Burrows from Goldman Sachs set a target price of $33.0 on 08/21/2025
- Michael Carroll from RBC Capital set a target price of $40.0 on 08/07/2025
- John Kim from BMO Capital set a target price of $35.0 on 07/16/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$557,000 of BECTON DICKINSON AND COMPANY lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to preventative screenings Issues related to maternal health Issues related to corporate taxation Tax incentives for domestic manufacturing Issues related to medical device supply chains and supply chain resiliency Issues related to medical research funding Issues related to medical device sterilization Issues related to medical device supply chain"
You can find more data on corporate lobbying on Quiver Quantitative.
BDX Congressional Stock Trading
Members of Congress have traded $BDX stock 5 times in the past 6 months. Of those trades, 3 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $BDX stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 06/17 and 1 sale worth up to $15,000 on 06/24.
- REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 1 purchase worth up to $15,000 on 05/15 and 1 sale worth up to $15,000 on 04/08.
- REPRESENTATIVE THOMAS H. KEAN, JR. purchased up to $15,000 on 05/13.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
BDX Insider Trading Activity
BDX insiders have traded $BDX stock on the open market 9 times in the past 6 months. Of those trades, 1 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $BDX stock by insiders over the last 6 months:
- GREGORY HAYES purchased 5,250 shares for an estimated $1,005,742
- CLAIRE FRASER has made 0 purchases and 2 sales selling 1,780 shares for an estimated $337,892.
- MICHAEL DAVID GARRISON (EVP & President, Medical) has made 0 purchases and 3 sales selling 1,664 shares for an estimated $308,141.
- DAVID SHAN (EVP and Chief ISC Officer) sold 1,166 shares for an estimated $199,607
- RICHARD BYRD (EVP & President Interventional) sold 459 shares for an estimated $105,570
- MICHAEL FELD (EVP & President, Life Sciences) sold 57 shares for an estimated $11,285
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
BDX Hedge Fund Activity
We have seen 702 institutional investors add shares of BDX stock to their portfolio, and 926 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MORGAN STANLEY removed 4,598,284 shares (-53.5%) from their portfolio in Q2 2025, for an estimated $792,054,419
- VANGUARD GROUP INC added 4,305,947 shares (+15.4%) to their portfolio in Q2 2025, for an estimated $741,699,370
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 3,603,168 shares (+28.7%) to their portfolio in Q2 2025, for an estimated $620,645,688
- BLACKROCK, INC. added 3,389,963 shares (+14.2%) to their portfolio in Q2 2025, for an estimated $583,921,126
- FIRST EAGLE INVESTMENT MANAGEMENT, LLC added 3,268,478 shares (+59.2%) to their portfolio in Q2 2025, for an estimated $562,995,335
- GQG PARTNERS LLC removed 3,011,583 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $518,745,171
- GENERATION INVESTMENT MANAGEMENT LLP removed 2,537,140 shares (-47.9%) from their portfolio in Q2 2025, for an estimated $437,022,365
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BDX Analyst Ratings
Wall Street analysts have issued reports on $BDX in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 06/03/2025
- Morgan Stanley issued a "Overweight" rating on 05/06/2025
- Stifel issued a "Buy" rating on 05/02/2025
To track analyst ratings and price targets for BDX, check out Quiver Quantitative's $BDX forecast page.
BDX Price Targets
Multiple analysts have issued price targets for $BDX recently. We have seen 7 analysts offer price targets for $BDX in the last 6 months, with a median target of $200.0.
Here are some recent targets:
- Patrick Wood from Morgan Stanley set a target price of $197.0 on 08/11/2025
- Jason Bednar from Piper Sandler set a target price of $200.0 on 08/08/2025
- Lawrence Biegelsen from Wells Fargo set a target price of $184.0 on 08/08/2025
- Matt Miksic from Barclays set a target price of $241.0 on 06/03/2025
- Joanna Wiensch from Citigroup set a target price of $185.0 on 05/22/2025
- Rick Wise from Stifel set a target price of $224.0 on 05/02/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$650,000 of BOOZ ALLEN HAMILTON INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"- H.R. 3838 / S. 2296 FY26 National Defense Authorization Act, all provisions related to Cybersecurity, Acquisition, and Missile Defense. - Emerging Technologies - Intelligence Authorization Act, 2026, all provisions related to: Cybersecurity - Cybersecurity - IRS Modernization - FAA Modernization - Artificial Intelligence - Quantum - Cyber - H.R. 4016/ S. ## FY26 Defense Appropriations, all provisions related to Missile Defense - H.R. 1 Reconciliation Bill, all provisions related to Missile Defense - Issues related to Health IT Modernization"
You can find more data on corporate lobbying on Quiver Quantitative.
BAH Hedge Fund Activity
We have seen 346 institutional investors add shares of BAH stock to their portfolio, and 479 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 2,296,316 shares (+inf%) to their portfolio in Q2 2025, for an estimated $239,115,385
- PRICE T ROWE ASSOCIATES INC /MD/ removed 1,447,160 shares (-20.5%) from their portfolio in Q2 2025, for an estimated $150,692,770
- PRIMECAP MANAGEMENT CO/CA/ added 1,207,058 shares (+2011.8%) to their portfolio in Q2 2025, for an estimated $125,690,949
- JPMORGAN CHASE & CO removed 1,120,283 shares (-45.0%) from their portfolio in Q2 2025, for an estimated $116,655,068
- JANUS HENDERSON GROUP PLC removed 1,081,675 shares (-44.5%) from their portfolio in Q2 2025, for an estimated $112,634,817
- MAN GROUP PLC removed 1,067,599 shares (-74.5%) from their portfolio in Q2 2025, for an estimated $111,169,083
- TWO SIGMA INVESTMENTS, LP removed 1,044,793 shares (-88.1%) from their portfolio in Q2 2025, for an estimated $108,794,295
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BAH Analyst Ratings
Wall Street analysts have issued reports on $BAH in the last several months. We have seen 2 firms issue buy ratings on the stock, and 2 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Underweight" rating on 07/28/2025
- William Blair issued a "Outperform" rating on 07/22/2025
- Goldman Sachs issued a "Sell" rating on 05/28/2025
- Wells Fargo issued a "Overweight" rating on 05/27/2025
To track analyst ratings and price targets for BAH, check out Quiver Quantitative's $BAH forecast page.
BAH Price Targets
Multiple analysts have issued price targets for $BAH recently. We have seen 7 analysts offer price targets for $BAH in the last 6 months, with a median target of $119.0.
Here are some recent targets:
- Jonathan Siegmann from Stifel set a target price of $119.0 on 07/28/2025
- Seth Seifman from JP Morgan set a target price of $122.0 on 07/28/2025
- Gavin Parsons from UBS set a target price of $119.0 on 07/28/2025
- Noah Poponak from Goldman Sachs set a target price of $94.0 on 05/28/2025
- David Strauss from Barclays set a target price of $120.0 on 05/28/2025
- Matthew Akers from Wells Fargo set a target price of $135.0 on 05/27/2025
- Tobey Sommer from Truist Securities set a target price of $110.0 on 04/14/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$130,000 of HORMEL FOODS CORPORATION lobbying was just disclosed, from Q2 of 2024, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"CO2 supply, NSIS and line speed parameters, Animal disease prevention Worker visa programs for agriculture and food processing workers Worker visas for agriculture and food processing Food Labeling safety, Nutritional standards, dietary guidelines, Front of Pack labeling Increased market access for Food and Agriculture Products worldwide and in countries such as China, Japan, Mexico, EU, Canada and England. Steel tinplate tariffs. Maintain and do not increase the the federal corporate tax rate Identify avenues to minimize or eliminate tariffs on necessary packaging materials. Steel tinplate tariffs."
You can find more data on corporate lobbying on Quiver Quantitative.
HRL Congressional Stock Trading
Members of Congress have traded $HRL stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $HRL stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 07/16 and 1 sale worth up to $15,000 on 07/22.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
HRL Insider Trading Activity
HRL insiders have traded $HRL stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $HRL stock by insiders over the last 6 months:
- ELSA A MURANO sold 4,500 shares for an estimated $136,800
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
HRL Hedge Fund Activity
We have seen 320 institutional investors add shares of HRL stock to their portfolio, and 364 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CITADEL ADVISORS LLC added 3,476,309 shares (+115.9%) to their portfolio in Q2 2025, for an estimated $105,158,347
- STIFEL FINANCIAL CORP removed 3,383,050 shares (-65.5%) from their portfolio in Q2 2025, for an estimated $102,337,262
- PACER ADVISORS, INC. removed 2,303,912 shares (-98.6%) from their portfolio in Q2 2025, for an estimated $69,693,338
- D. E. SHAW & CO., INC. removed 1,238,687 shares (-76.1%) from their portfolio in Q2 2025, for an estimated $37,470,281
- J. GOLDMAN & CO LP added 1,078,328 shares (+inf%) to their portfolio in Q2 2025, for an estimated $32,619,422
- SQUAREPOINT OPS LLC removed 1,056,614 shares (-98.9%) from their portfolio in Q2 2025, for an estimated $31,962,573
- UBS GROUP AG added 964,466 shares (+32.2%) to their portfolio in Q2 2025, for an estimated $29,175,096
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
HRL Analyst Ratings
Wall Street analysts have issued reports on $HRL in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Goldman Sachs issued a "Buy" rating on 08/29/2025
- Barclays issued a "Overweight" rating on 08/29/2025
- JP Morgan issued a "Overweight" rating on 08/29/2025
To track analyst ratings and price targets for HRL, check out Quiver Quantitative's $HRL forecast page.
HRL Price Targets
Multiple analysts have issued price targets for $HRL recently. We have seen 6 analysts offer price targets for $HRL in the last 6 months, with a median target of $31.0.
Here are some recent targets:
- Adam Samuelson from Goldman Sachs set a target price of $31.0 on 08/29/2025
- Peter Galbo from B of A Securities set a target price of $28.0 on 08/29/2025
- Benjamin Theurer from Barclays set a target price of $34.0 on 08/29/2025
- Thomas Palmer from JP Morgan set a target price of $30.0 on 08/29/2025
- Pooran Sharma from Stephens & Co. set a target price of $31.0 on 05/22/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$60,000 of TIMKEN COMPANY lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Fiscal year appropriations Environmental Issues Defense Issues Immigration Issues Labor/Workforce Issues Tax Issues Trade Issues"
You can find more data on corporate lobbying on Quiver Quantitative.
TKR Congressional Stock Trading
Members of Congress have traded $TKR stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $TKR stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 06/11 and 1 sale worth up to $15,000 on 06/17.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
TKR Insider Trading Activity
TKR insiders have traded $TKR stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $TKR stock by insiders over the last 6 months:
- HANSAL N. PATEL (EVP, GC and Secretary) sold 4,869 shares for an estimated $385,381
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
TKR Hedge Fund Activity
We have seen 211 institutional investors add shares of TKR stock to their portfolio, and 257 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- THRIVENT FINANCIAL FOR LUTHERANS removed 1,506,967 shares (-97.9%) from their portfolio in Q2 2025, for an estimated $109,330,455
- COOKE & BIELER LP added 855,961 shares (+341.0%) to their portfolio in Q2 2025, for an estimated $62,099,970
- FMR LLC removed 815,427 shares (-18.7%) from their portfolio in Q2 2025, for an estimated $59,159,228
- FULLER & THALER ASSET MANAGEMENT, INC. added 647,917 shares (+47.0%) to their portfolio in Q2 2025, for an estimated $47,006,378
- ROYAL LONDON ASSET MANAGEMENT LTD removed 485,318 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $34,879,804
- AMERICAN CENTURY COMPANIES INC added 455,050 shares (+13.4%) to their portfolio in Q2 2025, for an estimated $33,013,877
- INVESCO LTD. added 427,879 shares (+241.7%) to their portfolio in Q2 2025, for an estimated $31,042,621
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
TKR Analyst Ratings
Wall Street analysts have issued reports on $TKR in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 06/24/2025
- Evercore ISI Group issued a "Outperform" rating on 05/19/2025
- Oppenheimer issued a "Outperform" rating on 05/01/2025
- Morgan Stanley issued a "Overweight" rating on 04/16/2025
To track analyst ratings and price targets for TKR, check out Quiver Quantitative's $TKR forecast page.
TKR Price Targets
Multiple analysts have issued price targets for $TKR recently. We have seen 8 analysts offer price targets for $TKR in the last 6 months, with a median target of $80.0.
Here are some recent targets:
- Michael Shlisky from DA Davidson set a target price of $80.0 on 07/22/2025
- Kyle Menges from Citigroup set a target price of $80.0 on 06/24/2025
- David Raso from Evercore ISI Group set a target price of $85.0 on 05/19/2025
- Bryan Blair from Oppenheimer set a target price of $88.0 on 05/01/2025
- Chris Dankert from Loop Capital set a target price of $65.0 on 04/17/2025
- Angel Castillo from Morgan Stanley set a target price of $88.0 on 04/16/2025
- Joe Ritchie from Goldman Sachs set a target price of $75.0 on 04/02/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$50,000 of OCEANEERING INTERNATIONAL INC lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Provided Personal and Professional Staff members with an update to the programs that Oceaneering supports with NASA and commercial space entities Provided Personal and Professional Staff Members with an update on programs that Oceaneering currently supports for the Department of Defense Provided Personal and Professional Staff members with an update on the Energy Programs that Oceaneering is involved in. Provided Personal and Professional Staff Members with information about Oceaneering's transportation and warehousing projects and programs"
You can find more data on corporate lobbying on Quiver Quantitative.
OII Insider Trading Activity
OII insiders have traded $OII stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $OII stock by insiders over the last 6 months:
- ALAN R CURTIS (SVP and CFO) sold 14,840 shares for an estimated $361,474
- KAREN H BEACHY sold 5,300 shares for an estimated $100,382
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
OII Hedge Fund Activity
We have seen 158 institutional investors add shares of OII stock to their portfolio, and 169 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CONGRESS ASSET MANAGEMENT CO removed 1,790,545 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $37,100,092
- BALYASNY ASSET MANAGEMENT L.P. added 1,227,950 shares (+916.6%) to their portfolio in Q2 2025, for an estimated $25,443,124
- BLACKROCK, INC. removed 879,127 shares (-5.3%) from their portfolio in Q2 2025, for an estimated $18,215,511
- BROWN ADVISORY INC added 799,718 shares (+12.2%) to their portfolio in Q2 2025, for an estimated $16,570,156
- FIL LTD removed 796,575 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $16,505,034
- FMR LLC removed 668,636 shares (-70.1%) from their portfolio in Q2 2025, for an estimated $13,854,137
- MILLENNIUM MANAGEMENT LLC added 630,543 shares (+619.2%) to their portfolio in Q2 2025, for an estimated $13,064,850
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$40,000 of OSHKOSH CORPORATION lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"US manufacturing and international competitiveness US manufacturing and international competitiveness US manufacturing and international competitiveness"
You can find more data on corporate lobbying on Quiver Quantitative.
OSK Insider Trading Activity
OSK insiders have traded $OSK stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $OSK stock by insiders over the last 6 months:
- IGNACIO A CORTINA (EVP, CL&AO & Secretary) has made 0 purchases and 2 sales selling 12,725 shares for an estimated $1,764,109.
- JAMES C FREEDERS (SVP, Finance and Controller) has made 0 purchases and 3 sales selling 12,125 shares for an estimated $1,656,956.
- ANUPAM KHARE (SVP/Chief Information Officer) sold 4,000 shares for an estimated $556,120
- BRYAN K BRANDT (SVP & Chief Marketing Officer) sold 1,731 shares for an estimated $243,058
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
OSK Hedge Fund Activity
We have seen 247 institutional investors add shares of OSK stock to their portfolio, and 308 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FULLER & THALER ASSET MANAGEMENT, INC. removed 583,083 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $66,203,243
- SG CAPITAL MANAGEMENT LLC added 557,006 shares (+inf%) to their portfolio in Q2 2025, for an estimated $63,242,461
- AMERICAN CENTURY COMPANIES INC added 529,907 shares (+22.8%) to their portfolio in Q2 2025, for an estimated $60,165,640
- PZENA INVESTMENT MANAGEMENT LLC added 525,887 shares (+inf%) to their portfolio in Q2 2025, for an estimated $59,709,209
- BLACKROCK, INC. added 524,179 shares (+8.4%) to their portfolio in Q2 2025, for an estimated $59,515,283
- UBS GROUP AG removed 449,022 shares (-66.1%) from their portfolio in Q2 2025, for an estimated $50,981,957
- BALYASNY ASSET MANAGEMENT L.P. removed 382,998 shares (-81.8%) from their portfolio in Q2 2025, for an estimated $43,485,592
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
OSK Analyst Ratings
Wall Street analysts have issued reports on $OSK in the last several months. We have seen 8 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Keybanc issued a "Overweight" rating on 08/26/2025
- UBS issued a "Buy" rating on 08/05/2025
- Baird issued a "Outperform" rating on 08/04/2025
- DA Davidson issued a "Buy" rating on 07/22/2025
- Goldman Sachs issued a "Buy" rating on 07/01/2025
- Citigroup issued a "Buy" rating on 06/24/2025
- B of A Securities issued a "Underperform" rating on 06/06/2025
To track analyst ratings and price targets for OSK, check out Quiver Quantitative's $OSK forecast page.
OSK Price Targets
Multiple analysts have issued price targets for $OSK recently. We have seen 11 analysts offer price targets for $OSK in the last 6 months, with a median target of $131.0.
Here are some recent targets:
- Steve Barger from Keybanc set a target price of $180.0 on 08/26/2025
- Michael Shlisky from DA Davidson set a target price of $160.0 on 08/05/2025
- Steven Fisher from UBS set a target price of $164.0 on 08/05/2025
- Mircea Dobre from Baird set a target price of $188.0 on 08/04/2025
- Jerry Revich from Goldman Sachs set a target price of $131.0 on 07/01/2025
- Kyle Menges from Citigroup set a target price of $130.0 on 06/24/2025
- Ross Gilardi from B of A Securities set a target price of $103.0 on 06/06/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$70,000 of ENERGIZER HOLDINGS INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"National Recycling Strategy; S.1008 - Setting Consumer Standards for Lithium-Ion Batteries Act; S.1194/H.R. 4040 - Recycling and Composting Accountability Act; S.1189 - Recycling Infrastructure and Accessibility Act of 2023. Congressional communications regarding battery and car care manufacturing, employment and sustainability issues; US-China competitiveness legislation regarding Generalized System of Preferences for manufacturing and trade with select developing countries for manufacturing/economic development purpose; H.R. 1 - One Big Beautiful Bill, Sec. 45X advanced manufacturing production tax credit language. Consumer safety issues and Consumer Product Safety Commission issues regarding battery safety. Congressional communications regarding battery and car care manufacturing, employment and sustainability issues; US-China competitiveness legislation regarding Generalized System of Preferences for manufacturing and trade with select developing countries for manufacturing/economic development purpose; H.R. 7024 - Tax Relief for American Families & Workers Act of 2024 re: manufacturing R&D tax credits. H.R. 1 - One Big Beautiful Bill, lobbying on Sec 45X advanced manufacturing production tax credit language."
You can find more data on corporate lobbying on Quiver Quantitative.
ENR Insider Trading Activity
ENR insiders have traded $ENR stock on the open market 7 times in the past 6 months. Of those trades, 7 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $ENR stock by insiders over the last 6 months:
- ROBERT V VITALE purchased 21,009 shares for an estimated $494,761
- DONAL L MULLIGAN purchased 10,000 shares for an estimated $236,600
- PATRICK J MOORE purchased 10,000 shares for an estimated $231,000
- KEVIN J HUNT purchased 5,000 shares for an estimated $114,250
- CYNTHIA J BRINKLEY purchased 4,000 shares for an estimated $92,480
- MARK STEPHEN LAVIGNE (President and CEO) purchased 4,000 shares for an estimated $86,680
- JOHN J DRABIK (EVP, Chief Financial Officer) purchased 1,000 shares for an estimated $23,860
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ENR Hedge Fund Activity
We have seen 135 institutional investors add shares of ENR stock to their portfolio, and 205 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FULLER & THALER ASSET MANAGEMENT, INC. added 1,802,664 shares (+86.1%) to their portfolio in Q2 2025, for an estimated $36,341,706
- ARMISTICE CAPITAL, LLC removed 592,144 shares (-52.5%) from their portfolio in Q2 2025, for an estimated $11,937,623
- CLARKSTON CAPITAL PARTNERS, LLC added 583,465 shares (+13.9%) to their portfolio in Q2 2025, for an estimated $11,762,654
- PRINCIPAL FINANCIAL GROUP INC removed 581,905 shares (-64.1%) from their portfolio in Q2 2025, for an estimated $11,731,204
- CITADEL ADVISORS LLC added 541,601 shares (+2892.4%) to their portfolio in Q2 2025, for an estimated $10,918,676
- MORGAN STANLEY added 539,774 shares (+66.9%) to their portfolio in Q2 2025, for an estimated $10,881,843
- BLACKROCK, INC. removed 537,688 shares (-5.2%) from their portfolio in Q2 2025, for an estimated $10,839,790
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ENR Analyst Ratings
Wall Street analysts have issued reports on $ENR in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Truist Securities issued a "Buy" rating on 05/08/2025
To track analyst ratings and price targets for ENR, check out Quiver Quantitative's $ENR forecast page.
ENR Price Targets
Multiple analysts have issued price targets for $ENR recently. We have seen 5 analysts offer price targets for $ENR in the last 6 months, with a median target of $28.0.
Here are some recent targets:
- Bill Chappell from Truist Securities set a target price of $35.0 on 08/06/2025
- Lauren Lieberman from Barclays set a target price of $27.0 on 08/06/2025
- Peter Grom from UBS set a target price of $29.0 on 08/05/2025
- Andrea Teixeira from JP Morgan set a target price of $28.0 on 07/25/2025
- Brian McNamara from Canaccord Genuity set a target price of $27.0 on 05/07/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$1,570,000 of TAKEDA PHARMACEUTICALS AMERICA INC lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"FY 2025 Budget Resolution - Pharmaceutical Related Provisions Policies to enhance patient access to medicines in Medicaid including rebate, waiver policy and funding issues Policies to enhance patient access to medicines in Medicare Proposals related to amending the protected classes in Medicare Medicare telehealth proposals CMS Transparency in Coverage Final Rule (CMS-9915-F) Medicare Drug Price Negotiation Program: Selected Drugs for Initial Price Applicability Year 2026 Medicare Drug Price Negotiation Program: Selected Drugs for Initial Price Applicability Year 2027 Medicare Drug Price Negotiation Program: Selected Drugs for Initial Price Applicability Year 2028 Discussions on spillover related to the IRA Discussions on reforming the Inflation Reduction Act Discussions on treatment of small molecule drugs related to Inflation Reduction Act Discussions on treatment of small molecule drugs related to Inflation Reduction Act H.R.1 492, S. 832, EPIC Act of 2025, All Pharmaceutical Related Provisions H.R. 946, Optimizing Research Progress Hope and New (ORPHAN) Cures Act Clarify or reform the 340B program Issues related to patient access of plasma therapies Global pharmaceutical supply chain operations and manufacturing locations Most Favored Nation/International Reference Pricing Issues related to rare disease diagnosis and access to care Issues related to Pharmacy Benefit Managers (PBMs) H.R. 1476, S. 694, PLASMA Act Administration's Global Tax Proposal General issues around 2025 Reconciliation/Inbound Concerns Issues related to proposed Tariffs - all pharmaceutical related provisions Discussions around Supply Chain implications"
You can find more data on corporate lobbying on Quiver Quantitative.
TAK Hedge Fund Activity
We have seen 180 institutional investors add shares of TAK stock to their portfolio, and 137 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC added 2,842,012 shares (+1152.2%) to their portfolio in Q2 2025, for an estimated $43,937,505
- UBS GROUP AG added 2,270,084 shares (+129.4%) to their portfolio in Q2 2025, for an estimated $35,095,498
- MORGAN STANLEY added 1,917,066 shares (+33.6%) to their portfolio in Q2 2025, for an estimated $29,637,840
- SOLEUS CAPITAL MANAGEMENT, L.P. removed 1,180,000 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $17,546,600
- BLACKROCK, INC. added 920,044 shares (+35.0%) to their portfolio in Q2 2025, for an estimated $14,223,880
- ADAGE CAPITAL PARTNERS GP, L.L.C. removed 899,298 shares (-26.2%) from their portfolio in Q2 2025, for an estimated $13,903,147
- VAN ECK ASSOCIATES CORP removed 840,952 shares (-38.7%) from their portfolio in Q2 2025, for an estimated $13,001,117
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$60,000 of FIRST SOLAR lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Prohibit China and other CCP-linked companies from accessing 45X tax credits."
You can find more data on corporate lobbying on Quiver Quantitative.
FSLR Congressional Stock Trading
Members of Congress have traded $FSLR stock 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $FSLR stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 04/08, 02/25.
- REPRESENTATIVE DAVE MIN sold up to $15,000 on 03/19.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
FSLR Insider Trading Activity
FSLR insiders have traded $FSLR stock on the open market 70 times in the past 6 months. Of those trades, 0 have been purchases and 70 have been sales.
Here’s a breakdown of recent trading of $FSLR stock by insiders over the last 6 months:
- MARK R WIDMAR (Chief Executive Officer) has made 0 purchases and 32 sales selling 54,809 shares for an estimated $9,079,981.
- MARKUS GLOECKLER (Chief Technology Officer) has made 0 purchases and 3 sales selling 10,315 shares for an estimated $1,582,896.
- ALEXANDER R. BRADLEY (Chief Financial Officer) has made 0 purchases and 4 sales selling 9,784 shares for an estimated $1,451,223.
- KUNTAL KUMAR VERMA (Chief Manufacturing Officer) has made 0 purchases and 14 sales selling 8,801 shares for an estimated $1,195,131.
- PATRICK JAMES BUEHLER (Chief Product Officer) has made 0 purchases and 4 sales selling 3,846 shares for an estimated $616,887.
- MICHAEL KORALEWSKI (Chief Supply Chain Officer) has made 0 purchases and 3 sales selling 3,412 shares for an estimated $528,387.
- JASON E. DYMBORT (General Counsel and Secretary) has made 0 purchases and 3 sales selling 2,507 shares for an estimated $483,860.
- NATHAN B. THEURER (VP - Global Controller and CAO) has made 0 purchases and 3 sales selling 752 shares for an estimated $133,675.
- CAROLINE STOCKDALE (Chief People and Comm. Officer) has made 0 purchases and 2 sales selling 568 shares for an estimated $75,790.
- GEORGES ANTOUN (Chief Commercial Officer) has made 0 purchases and 2 sales selling 376 shares for an estimated $50,173.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
FSLR Hedge Fund Activity
We have seen 476 institutional investors add shares of FSLR stock to their portfolio, and 463 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 4,339,806 shares (+625.6%) to their portfolio in Q2 2025, for an estimated $718,411,485
- D. E. SHAW & CO., INC. removed 1,687,726 shares (-90.2%) from their portfolio in Q2 2025, for an estimated $279,386,162
- GOLDMAN SACHS GROUP INC removed 1,300,186 shares (-82.6%) from their portfolio in Q2 2025, for an estimated $215,232,790
- BLACKROCK, INC. added 1,097,952 shares (+9.3%) to their portfolio in Q2 2025, for an estimated $181,754,974
- CITADEL ADVISORS LLC added 910,803 shares (+485.9%) to their portfolio in Q2 2025, for an estimated $150,774,328
- VIKING GLOBAL INVESTORS LP added 854,919 shares (+60.6%) to their portfolio in Q2 2025, for an estimated $141,523,291
- UBS GROUP AG added 824,862 shares (+54.4%) to their portfolio in Q2 2025, for an estimated $136,547,655
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
FSLR Analyst Ratings
Wall Street analysts have issued reports on $FSLR in the last several months. We have seen 18 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 08/05/2025
- BMO Capital issued a "Outperform" rating on 08/01/2025
- B of A Securities issued a "Buy" rating on 07/22/2025
- JP Morgan issued a "Overweight" rating on 07/22/2025
- Susquehanna issued a "Positive" rating on 07/21/2025
- Jefferies issued a "Buy" rating on 07/15/2025
- RBC Capital issued a "Outperform" rating on 07/01/2025
To track analyst ratings and price targets for FSLR, check out Quiver Quantitative's $FSLR forecast page.
FSLR Price Targets
Multiple analysts have issued price targets for $FSLR recently. We have seen 19 analysts offer price targets for $FSLR in the last 6 months, with a median target of $208.0.
Here are some recent targets:
- Joseph Osha from Guggenheim set a target price of $287.0 on 08/22/2025
- Gordon Johnson from GLJ Research set a target price of $214.06 on 08/12/2025
- Jon Windham from UBS set a target price of $275.0 on 08/05/2025
- Ameet Thakkar from BMO Capital set a target price of $203.0 on 08/01/2025
- Biju Perincheril from Susquehanna set a target price of $222.0 on 08/01/2025
- Mark Strouse from JP Morgan set a target price of $208.0 on 07/22/2025
- Dimple Gosai from B of A Securities set a target price of $201.0 on 07/22/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$20,000 of PG&E lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Energy and Utilites."
You can find more data on corporate lobbying on Quiver Quantitative.
PCG Congressional Stock Trading
Members of Congress have traded $PCG stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $PCG stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 02/26.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
PCG Insider Trading Activity
PCG insiders have traded $PCG stock on the open market 8 times in the past 6 months. Of those trades, 3 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $PCG stock by insiders over the last 6 months:
- MARLENE SANTOS sold 125,702 shares for an estimated $2,057,741
- CARLA J PETERMAN (EVP/Corp. Affairs & CSO) has made 0 purchases and 2 sales selling 65,040 shares for an estimated $1,094,947.
- JASON M GLICKMAN sold 40,239 shares for an estimated $632,154
- III MARK E FERGUSON sold 7,000 shares for an estimated $106,050
- LEO P DENAULT purchased 6,300 shares for an estimated $100,548
- RAJAT BAHRI purchased 3,170 shares for an estimated $50,054
- CARLOS M HERNANDEZ purchased 3,142 shares for an estimated $49,989
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
PCG Hedge Fund Activity
We have seen 422 institutional investors add shares of PCG stock to their portfolio, and 419 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO removed 65,729,195 shares (-53.2%) from their portfolio in Q2 2025, for an estimated $916,264,978
- FMR LLC removed 28,132,497 shares (-17.9%) from their portfolio in Q2 2025, for an estimated $392,167,008
- WELLINGTON MANAGEMENT GROUP LLP removed 13,917,050 shares (-52.6%) from their portfolio in Q2 2025, for an estimated $194,003,677
- BANK OF AMERICA CORP /DE/ added 10,352,477 shares (+91.4%) to their portfolio in Q2 2025, for an estimated $144,313,529
- PRICE T ROWE ASSOCIATES INC /MD/ added 8,632,819 shares (+29.9%) to their portfolio in Q2 2025, for an estimated $120,341,496
- AQR CAPITAL MANAGEMENT LLC added 8,212,761 shares (+49.9%) to their portfolio in Q2 2025, for an estimated $114,485,888
- COVALIS CAPITAL LLP added 7,935,782 shares (+2761.2%) to their portfolio in Q2 2025, for an estimated $110,624,801
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
PCG Analyst Ratings
Wall Street analysts have issued reports on $PCG in the last several months. We have seen 4 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Morgan Stanley issued a "Underweight" rating on 05/22/2025
- Mizuho issued a "Outperform" rating on 05/19/2025
- Jefferies issued a "Buy" rating on 04/23/2025
- BMO Capital issued a "Outperform" rating on 04/14/2025
- Barclays issued a "Overweight" rating on 04/09/2025
To track analyst ratings and price targets for PCG, check out Quiver Quantitative's $PCG forecast page.
PCG Price Targets
Multiple analysts have issued price targets for $PCG recently. We have seen 9 analysts offer price targets for $PCG in the last 6 months, with a median target of $19.0.
Here are some recent targets:
- Nicholas Campanella from Barclays set a target price of $20.0 on 07/22/2025
- Stephen Byrd from Morgan Stanley set a target price of $18.0 on 05/22/2025
- Anthony Crowdell from Mizuho set a target price of $21.0 on 05/19/2025
- Michael Lonegan from Evercore ISI Group set a target price of $17.0 on 04/28/2025
- Shahriar Pourreza from Guggenheim set a target price of $17.0 on 04/25/2025
- Julien Dumoulin-Smith from Jefferies set a target price of $22.0 on 04/23/2025
- James Thalacker from BMO Capital set a target price of $22.0 on 04/14/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$30,000 of KELLOGG HANSEN TODD FIGEL & FREDERICK ON BEHALF OF FUBOTV lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Antitrust; acquisition of FuboTV by the Walt Disney Company"
You can find more data on corporate lobbying on Quiver Quantitative.
FUBO Insider Trading Activity
FUBO insiders have traded $FUBO stock on the open market 20 times in the past 6 months. Of those trades, 0 have been purchases and 20 have been sales.
Here’s a breakdown of recent trading of $FUBO stock by insiders over the last 6 months:
- DANIEL V LEFF has made 0 purchases and 11 sales selling 260,788 shares for an estimated $990,121.
- EDGAR JR BRONFMAN (Executive Chairman) has made 0 purchases and 6 sales selling 119,388 shares for an estimated $435,390.
- LAURA DIANE ONOPCHENKO sold 100,000 shares for an estimated $392,000
- IGNACIO FIGUERAS sold 66,061 shares for an estimated $281,221
- JOHN JANEDIS (Chief Financial Officer) sold 25,823 shares for an estimated $107,423
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
FUBO Hedge Fund Activity
We have seen 123 institutional investors add shares of FUBO stock to their portfolio, and 119 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VANGUARD GROUP INC added 8,231,798 shares (+38.9%) to their portfolio in Q2 2025, for an estimated $31,774,740
- RENAISSANCE TECHNOLOGIES LLC added 7,548,900 shares (+99.8%) to their portfolio in Q2 2025, for an estimated $29,138,754
- D. E. SHAW & CO., INC. removed 6,255,433 shares (-51.5%) from their portfolio in Q2 2025, for an estimated $24,145,971
- TWO SIGMA INVESTMENTS, LP added 4,018,515 shares (+201.6%) to their portfolio in Q2 2025, for an estimated $15,511,467
- TWO SIGMA ADVISERS, LP added 3,399,000 shares (+564.8%) to their portfolio in Q2 2025, for an estimated $13,120,140
- UBS GROUP AG added 3,124,020 shares (+156.8%) to their portfolio in Q2 2025, for an estimated $12,058,717
- JUMP FINANCIAL, LLC added 2,436,479 shares (+189.6%) to their portfolio in Q2 2025, for an estimated $9,404,808
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
FUBO Analyst Ratings
Wall Street analysts have issued reports on $FUBO in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wedbush issued a "Outperform" rating on 07/30/2025
- Needham issued a "Buy" rating on 07/30/2025
To track analyst ratings and price targets for FUBO, check out Quiver Quantitative's $FUBO forecast page.
FUBO Price Targets
Multiple analysts have issued price targets for $FUBO recently. We have seen 3 analysts offer price targets for $FUBO in the last 6 months, with a median target of $6.0.
Here are some recent targets:
- Alicia Reese from Wedbush set a target price of $6.0 on 07/30/2025
- Laura Martin from Needham set a target price of $4.25 on 07/30/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$20,000 of SOUTHEASTERN COMMUNITY COLLEGE lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"None"
You can find more data on corporate lobbying on Quiver Quantitative.
EML Insider Trading Activity
EML insiders have traded $EML stock on the open market 18 times in the past 6 months. Of those trades, 18 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $EML stock by insiders over the last 6 months:
- FREDERICK D. DISANTO has made 18 purchases buying 16,785 shares for an estimated $383,331 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
EML Hedge Fund Activity
We have seen 28 institutional investors add shares of EML stock to their portfolio, and 29 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VICTORY CAPITAL MANAGEMENT INC removed 46,835 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $1,068,774
- BLACKROCK, INC. added 27,438 shares (+9.6%) to their portfolio in Q2 2025, for an estimated $626,135
- SEGALL BRYANT & HAMILL, LLC removed 25,748 shares (-46.7%) from their portfolio in Q2 2025, for an estimated $587,569
- MINERVA ADVISORS LLC added 19,066 shares (+3.8%) to their portfolio in Q2 2025, for an estimated $435,086
- LOS ANGELES CAPITAL MANAGEMENT LLC added 14,274 shares (+inf%) to their portfolio in Q2 2025, for an estimated $325,732
- BRIDGEWAY CAPITAL MANAGEMENT, LLC removed 9,480 shares (-12.6%) from their portfolio in Q2 2025, for an estimated $216,333
- GAMCO INVESTORS, INC. ET AL added 8,999 shares (+1.8%) to their portfolio in Q2 2025, for an estimated $205,357
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$85,000 of MCCORMICK & COMPANY INCORPORATED lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to tariffs Issues related to upcoming tax debate"
You can find more data on corporate lobbying on Quiver Quantitative.
MKC Congressional Stock Trading
Members of Congress have traded $MKC stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $MKC stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN purchased up to $15,000 on 07/22.
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 04/08.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
MKC Insider Trading Activity
MKC insiders have traded $MKC stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $MKC stock by insiders over the last 6 months:
- LAWRENCE ERIK KURZIUS sold 50,000 shares for an estimated $4,090,300
- KATHERINE JENKINS (Chief Growth Officer) has made 0 purchases and 3 sales selling 7,642 shares for an estimated $583,696.
- MARITZA GOMEZ MONTIEL sold 5,912 shares for an estimated $488,745
- GREGORY REPAS (V.P. & Controller) sold 2,750 shares for an estimated $223,905
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
MKC Hedge Fund Activity
We have seen 453 institutional investors add shares of MKC stock to their portfolio, and 561 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SELECT EQUITY GROUP, L.P. removed 1,560,869 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $118,345,087
- FRANKLIN RESOURCES INC removed 1,533,979 shares (-31.8%) from their portfolio in Q2 2025, for an estimated $116,306,287
- WELLINGTON MANAGEMENT GROUP LLP added 1,465,917 shares (+706.1%) to their portfolio in Q2 2025, for an estimated $111,145,826
- MILLENNIUM MANAGEMENT LLC added 1,428,542 shares (+108.6%) to their portfolio in Q2 2025, for an estimated $108,312,054
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 1,297,316 shares (+31.4%) to their portfolio in Q2 2025, for an estimated $98,362,499
- GOLDMAN SACHS GROUP INC removed 1,205,306 shares (-51.1%) from their portfolio in Q2 2025, for an estimated $91,386,300
- INVESCO LTD. added 1,158,423 shares (+44.9%) to their portfolio in Q2 2025, for an estimated $87,831,631
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
MKC Price Targets
Multiple analysts have issued price targets for $MKC recently. We have seen 4 analysts offer price targets for $MKC in the last 6 months, with a median target of $80.0.
Here are some recent targets:
- Thomas Palmer from JP Morgan set a target price of $83.0 on 08/20/2025
- Matthew Smith from Stifel set a target price of $76.0 on 07/29/2025
- Thomas Palmer from Citigroup set a target price of $77.0 on 06/17/2025
- Bryan Adams from UBS set a target price of $83.0 on 06/16/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$30,000 of TRIMBLE INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Autonomous Self-Perception Combat Engineering Program (ASCEP II) Automated Pavement Inspection & Analysis for Military Airfields"
You can find more data on corporate lobbying on Quiver Quantitative.
TRMB Congressional Stock Trading
Members of Congress have traded $TRMB stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $TRMB stock by members of Congress over the last 6 months:
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 04/01.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
TRMB Insider Trading Activity
TRMB insiders have traded $TRMB stock on the open market 21 times in the past 6 months. Of those trades, 0 have been purchases and 21 have been sales.
Here’s a breakdown of recent trading of $TRMB stock by insiders over the last 6 months:
- ROBERT G PAINTER (President & CEO) has made 0 purchases and 8 sales selling 238,847 shares for an estimated $19,750,811.
- KAIGHAM GABRIEL has made 0 purchases and 2 sales selling 12,514 shares for an estimated $892,626.
- CHRISTOPHER F KEATING (Sr. VP Transportation) sold 5,709 shares for an estimated $411,036
- RONALD BISIO (Sr. Vice President) has made 0 purchases and 2 sales selling 4,000 shares for an estimated $296,625.
- JENNIFER ALLISON (Corporate VP, General Counsel) sold 3,156 shares for an estimated $252,480
- MARK DAVID SCHWARTZ (Senior VP, AECO) has made 0 purchases and 2 sales selling 2,880 shares for an estimated $227,448.
- PETER LARGE (Senior Vice President) has made 0 purchases and 3 sales selling 3,000 shares for an estimated $204,314.
- JAMES CALVIN DALTON has made 0 purchases and 2 sales selling 2,837 shares for an estimated $203,814.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
TRMB Hedge Fund Activity
We have seen 379 institutional investors add shares of TRMB stock to their portfolio, and 366 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MACQUARIE GROUP LTD removed 2,188,735 shares (-93.0%) from their portfolio in Q2 2025, for an estimated $166,300,085
- THRIVENT FINANCIAL FOR LUTHERANS removed 2,062,587 shares (-97.3%) from their portfolio in Q2 2025, for an estimated $156,715,360
- GENERATION INVESTMENT MANAGEMENT LLP added 1,449,315 shares (+19.1%) to their portfolio in Q2 2025, for an estimated $110,118,953
- MORGAN STANLEY added 1,430,477 shares (+11.8%) to their portfolio in Q2 2025, for an estimated $108,687,642
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,375,513 shares (-19.7%) from their portfolio in Q2 2025, for an estimated $104,511,477
- JANE STREET GROUP, LLC removed 727,502 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $55,275,601
- SCHRODER INVESTMENT MANAGEMENT GROUP removed 638,956 shares (-94.6%) from their portfolio in Q2 2025, for an estimated $48,547,876
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
TRMB Analyst Ratings
Wall Street analysts have issued reports on $TRMB in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Oppenheimer issued a "Outperform" rating on 08/07/2025
- Raymond James issued a "Outperform" rating on 08/07/2025
- JP Morgan issued a "Overweight" rating on 08/07/2025
- Piper Sandler issued a "Overweight" rating on 05/08/2025
To track analyst ratings and price targets for TRMB, check out Quiver Quantitative's $TRMB forecast page.
TRMB Price Targets
Multiple analysts have issued price targets for $TRMB recently. We have seen 4 analysts offer price targets for $TRMB in the last 6 months, with a median target of $93.5.
Here are some recent targets:
- Brian Gesuale from Raymond James set a target price of $93.0 on 08/07/2025
- Tami Zakaria from JP Morgan set a target price of $96.0 on 08/07/2025
- Kristen Owen from Oppenheimer set a target price of $94.0 on 08/07/2025
- Clarke Jeffries from Piper Sandler set a target price of $84.0 on 05/08/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$3,710,000 of PFIZER INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"HR 1 - One Big Beautiful Bill Act CDC Reform Vaccine Policy Reconciliation Research & Development S 526 - Pharmacy Benefit Manager Transparency Act of 2025 S 832 - EPIC Act of 2025 HR 1 - One Big Beautiful Bill Act CDC Reform Vaccine Policy Reconciliation Research & Development HR 946 - ORPHAN Cures Act HR 1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program HR 2214 - DRUG Act HR 2450 - Prescription Drug Transparency and Affordability Act PL 117-328 Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Biosimilars Access, Reimbursement and Reform 340B Reform Prescription Drug User Fee Act (PDUFA) Inflation Reduction Act (IRA) Pill Penalty Vaccine Coverage and Access Intellectual Property Protections PBM Reform Cancer Policies Drug Pricing S 526 - Pharmacy Benefit Manager Transparency Act of 2025 S 832 - EPIC Act of 2025 HR 946 - ORPHAN Cures Act HR 2450 - Prescription Drug Transparency and Affordability Act Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients PBM Reform Medicaid Prescription Drug Access Digital Therapeutics VICP Reform and Excise Tax Vaccine Injury Compensation Program International Supply Chain Global Access Tariffs Non-Tariff Trade Barriers"
You can find more data on corporate lobbying on Quiver Quantitative.
PFE Congressional Stock Trading
Members of Congress have traded $PFE stock 15 times in the past 6 months. Of those trades, 8 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $PFE stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN purchased up to $15,000 on 07/16.
- SENATOR RON WYDEN sold up to $15,000 on 06/03.
- REPRESENTATIVE JOSH GOTTHEIMER sold up to $15,000 on 06/03.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 4 times. They made 3 purchases worth up to $45,000 on 05/30, 04/29, 02/26 and 1 sale worth up to $50,000 on 03/31.
- REPRESENTATIVE ROBERT BRESNAHAN has traded it 3 times. They made 2 purchases worth up to $100,000 on 05/15, 02/25 and 1 sale worth up to $50,000 on 04/08.
- REPRESENTATIVE BRUCE WESTERMAN has traded it 2 times. They made 1 purchase worth up to $15,000 on 03/03 and 1 sale worth up to $15,000 on 04/21.
- REPRESENTATIVE JEFFERSON SHREVE has traded it 2 times. They made 1 purchase worth up to $50,000 on 02/24 and 1 sale worth up to $50,000 on 04/11.
- REPRESENTATIVE CAROL D. MILLER sold up to $15,000 on 03/10.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
PFE Insider Trading Activity
PFE insiders have traded $PFE stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $PFE stock by insiders over the last 6 months:
- JENNIFER B. DAMICO (SVP & Controller) sold 2,500 shares for an estimated $64,825
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
PFE Hedge Fund Activity
We have seen 1,267 institutional investors add shares of PFE stock to their portfolio, and 1,638 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP removed 26,490,160 shares (-25.6%) from their portfolio in Q2 2025, for an estimated $642,121,478
- BLACKROCK, INC. added 20,709,704 shares (+4.4%) to their portfolio in Q2 2025, for an estimated $502,003,224
- AMUNDI removed 14,642,887 shares (-28.1%) from their portfolio in Q2 2025, for an estimated $354,943,580
- MARSHALL WACE, LLP removed 13,641,127 shares (-96.8%) from their portfolio in Q2 2025, for an estimated $330,660,918
- CAPITAL WORLD INVESTORS removed 13,368,274 shares (-49.1%) from their portfolio in Q2 2025, for an estimated $324,046,961
- QUBE RESEARCH & TECHNOLOGIES LTD removed 10,711,578 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $259,648,650
- VICTORY CAPITAL MANAGEMENT INC added 10,400,851 shares (+220.6%) to their portfolio in Q2 2025, for an estimated $252,116,628
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
PFE Analyst Ratings
Wall Street analysts have issued reports on $PFE in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Guggenheim issued a "Buy" rating on 03/18/2025
To track analyst ratings and price targets for PFE, check out Quiver Quantitative's $PFE forecast page.
PFE Price Targets
Multiple analysts have issued price targets for $PFE recently. We have seen 6 analysts offer price targets for $PFE in the last 6 months, with a median target of $25.5.
Here are some recent targets:
- Terence Flynn from Morgan Stanley set a target price of $33.0 on 08/06/2025
- Tim Anderson from B of A Securities set a target price of $28.0 on 08/06/2025
- Andrew Baum from Citigroup set a target price of $26.0 on 08/06/2025
- Trung Huynh from UBS set a target price of $25.0 on 04/30/2025
- Carter Gould from Cantor Fitzgerald set a target price of $24.0 on 04/22/2025
- Asad Haider from Goldman Sachs set a target price of $25.0 on 04/08/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$125,000 of COHERUS BIOSCIENCES INC. lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to oncology, Medicare coverage, domestic production of essential drugs, supply chain security, PILLS Act, Biosecure Act, Loans and grants for biologic production Issues related to drug development, oncology, IRA implementation, supply chain security, BIOSECURE as a policy matter, PILLS Act, and domestic production of essential drugs. Strategic National Stockpile of acute radiation syndrome medical counter measures. Administration for Strategic Preparedness & Response."
You can find more data on corporate lobbying on Quiver Quantitative.
CHRS Insider Trading Activity
CHRS insiders have traded $CHRS stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $CHRS stock by insiders over the last 6 months:
- MATS WAHLSTROM sold 99,988 shares for an estimated $73,881
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CHRS Hedge Fund Activity
We have seen 47 institutional investors add shares of CHRS stock to their portfolio, and 66 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- POINT72 ASSET MANAGEMENT, L.P. removed 5,283,292 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $4,263,616
- RUBRIC CAPITAL MANAGEMENT LP removed 4,390,954 shares (-83.5%) from their portfolio in Q2 2025, for an estimated $3,211,104
- MILLENNIUM MANAGEMENT LLC removed 1,517,799 shares (-52.3%) from their portfolio in Q2 2025, for an estimated $1,109,966
- PANAGORA ASSET MANAGEMENT INC added 794,329 shares (+inf%) to their portfolio in Q2 2025, for an estimated $580,892
- LOS ANGELES CAPITAL MANAGEMENT LLC removed 603,597 shares (-60.9%) from their portfolio in Q2 2025, for an estimated $441,410
- VANGUARD GROUP INC removed 581,390 shares (-5.2%) from their portfolio in Q2 2025, for an estimated $425,170
- DISCIPLINED GROWTH INVESTORS INC /MN removed 566,746 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $457,364
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CHRS Analyst Ratings
Wall Street analysts have issued reports on $CHRS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 04/29/2025
To track analyst ratings and price targets for CHRS, check out Quiver Quantitative's $CHRS forecast page.
CHRS Price Targets
Multiple analysts have issued price targets for $CHRS recently. We have seen 2 analysts offer price targets for $CHRS in the last 6 months, with a median target of $4.025.
Here are some recent targets:
- Douglas Tsao from HC Wainwright & Co. set a target price of $7.0 on 04/29/2025
- Ashwani Verma from UBS set a target price of $1.05 on 04/24/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$30,000 of SOUTHEASTERN COLORADO WATER CONSERVANCY DISTRICT lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"monitoring funding for state revolving funds for safe drinking and clean water; any changes in how revolving funds work monitoring funding for Bureau of Reclamation and in particular the Arkansas Valley Conduit supporting legislation regarding the terms of payment of 35 percent cost of the Arkansas Valley Conduit; monitoring all Western water policy and regulatory issues"
You can find more data on corporate lobbying on Quiver Quantitative.
EML Insider Trading Activity
EML insiders have traded $EML stock on the open market 15 times in the past 6 months. Of those trades, 15 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $EML stock by insiders over the last 6 months:
- FREDERICK D. DISANTO has made 15 purchases buying 11,785 shares for an estimated $269,761 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
EML Hedge Fund Activity
We have seen 25 institutional investors add shares of EML stock to their portfolio, and 31 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VICTORY CAPITAL MANAGEMENT INC removed 46,835 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $1,068,774
- BLACKROCK, INC. added 27,438 shares (+9.6%) to their portfolio in Q2 2025, for an estimated $626,135
- SEGALL BRYANT & HAMILL, LLC removed 25,748 shares (-46.7%) from their portfolio in Q2 2025, for an estimated $587,569
- MINERVA ADVISORS LLC added 19,066 shares (+3.8%) to their portfolio in Q2 2025, for an estimated $435,086
- LOS ANGELES CAPITAL MANAGEMENT LLC added 14,274 shares (+inf%) to their portfolio in Q2 2025, for an estimated $325,732
- GAMCO INVESTORS, INC. ET AL added 8,999 shares (+1.8%) to their portfolio in Q2 2025, for an estimated $205,357
- BRIDGEWAY CAPITAL MANAGEMENT, LLC removed 8,800 shares (-10.4%) from their portfolio in Q1 2025, for an estimated $222,816
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$80,000 of CLEANSPARK INC lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Banking reform as it relates to digital assets Financial inclusion as it relates to digital assets Tax reform tariff issues related to imported goods Issues related to importing goods"
You can find more data on corporate lobbying on Quiver Quantitative.
CLSK Insider Trading Activity
CLSK insiders have traded $CLSK stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $CLSK stock by insiders over the last 6 months:
- ROGER PAUL BEYNON sold 50,000 shares for an estimated $525,285
- THOMAS LEIGH WOOD sold 44,444 shares for an estimated $357,329
- ZACHARY BRADFORD (CEO and President) sold 10,533 shares for an estimated $112,064
- AMANDA CAVALERI has made 0 purchases and 2 sales selling 13,000 shares for an estimated $103,600.
- S. MATTHEW SCHULTZ (Executive Chairman) sold 9,010 shares for an estimated $95,860
- SCOTT EUGENE GARRISON (Chief Operating Officer) sold 1,337 shares for an estimated $14,224
- GARY ANTHONY VECCHIARELLI (Chief Financial Officer) sold 717 shares for an estimated $7,628
- TAYLOR MONNIG (Chief Technology Officer) sold 239 shares for an estimated $2,542
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CLSK Hedge Fund Activity
We have seen 170 institutional investors add shares of CLSK stock to their portfolio, and 153 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GOLDMAN SACHS GROUP INC added 4,911,600 shares (+452.5%) to their portfolio in Q1 2025, for an estimated $33,005,952
- JANE STREET GROUP, LLC removed 4,495,966 shares (-98.9%) from their portfolio in Q1 2025, for an estimated $30,212,891
- STATE STREET CORP added 4,342,621 shares (+64.0%) to their portfolio in Q1 2025, for an estimated $29,182,413
- ASSENAGON ASSET MANAGEMENT S.A. removed 4,336,612 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $29,142,032
- MORGAN STANLEY removed 2,927,256 shares (-23.4%) from their portfolio in Q1 2025, for an estimated $19,671,160
- BANK OF AMERICA CORP /DE/ removed 2,776,210 shares (-80.8%) from their portfolio in Q1 2025, for an estimated $18,656,131
- DIMENSIONAL FUND ADVISORS LP added 2,560,425 shares (+1376.3%) to their portfolio in Q2 2025, for an estimated $28,241,487
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CLSK Analyst Ratings
Wall Street analysts have issued reports on $CLSK in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Chardan Capital issued a "Buy" rating on 08/12/2025
- B. Riley Securities issued a "Buy" rating on 08/08/2025
- Cantor Fitzgerald issued a "Overweight" rating on 08/08/2025
- Macquarie issued a "Outperform" rating on 08/08/2025
- Ladenburg Thalmann issued a "Buy" rating on 07/28/2025
- JP Morgan issued a "Overweight" rating on 07/28/2025
To track analyst ratings and price targets for CLSK, check out Quiver Quantitative's $CLSK forecast page.
CLSK Price Targets
Multiple analysts have issued price targets for $CLSK recently. We have seen 6 analysts offer price targets for $CLSK in the last 6 months, with a median target of $20.0.
Here are some recent targets:
- James McIlree from Chardan Capital set a target price of $20.0 on 08/12/2025
- Nick Giles from B. Riley Securities set a target price of $17.0 on 08/08/2025
- Paul Golding from Macquarie set a target price of $20.0 on 08/08/2025
- Brett Knoblauch from Cantor Fitzgerald set a target price of $26.0 on 08/08/2025
- Reginald Smith from JP Morgan set a target price of $15.0 on 07/28/2025
- Jon Hickman from Ladenburg Thalmann set a target price of $20.25 on 07/28/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.